# EDGAR Filing Document

**Accession Number:** 0001175454
**File Stem:** 0001175454-26-000010
**Filing Date:** 2026-2
**Character Count:** 234643
**Document Hash:** a056e2640367477e290c5390df14de6d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001175454-26-000010.hdr.sgml**: 20260205

**ACCESSION NUMBER**: 0001175454-26-000010

**CONFORMED SUBMISSION TYPE**: 8-K/A

**PUBLIC DOCUMENT COUNT**: 16

**CONFORMED PERIOD OF REPORT**: 20251031

**ITEM INFORMATION**: Completion of Acquisition or Disposition of Assets

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260205

**DATE AS OF CHANGE**: 20260205

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CORPAY, INC.
- **CENTRAL INDEX KEY:** 0001175454
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-BUSINESS SERVICES, NEC [7389]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-35004
- **FILM NUMBER:** 26600660

**BUSINESS ADDRESS:**
- **STREET 1:** 3280 PEACHTREE ROAD
- **STREET 2:** SUITE 2400
- **CITY:** ATLANTA
- **STATE:** GA
- **ZIP:** 30305
- **BUSINESS PHONE:** 800-877-9019

**MAIL ADDRESS:**
- **STREET 1:** 3280 PEACHTREE ROAD
- **STREET 2:** SUITE 2400
- **CITY:** ATLANTA
- **STATE:** GA
- **ZIP:** 30305

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** FLEETCOR TECHNOLOGIES INC
- **DATE OF NAME CHANGE:** 20020613

?xml version='1.0' encoding='ASCII'? flt-20251031

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

________________________________________________________

**FORM 8-K/A** 

**(Amendment No. 1)**

________________________________________________________

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d)**

**of the Securities Exchange Act of 1934**

**Date of Report (Date of Earliest Event Reported): October 31, 2025** 

________________________________________________________

**Corpay, Inc.** 

________________________________________________________

**(Exact name of registrant as specified in its charter)**

_______________________________________________________

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-35004** | **72-1074903** |
| **(State or other jurisdiction of<br>incorporation or organization)** | **(Commission<br>File Number)** | **(I.R.S. Employer<br>Identification No.)** |
| **3280 Peachtree Road, Suite 2400** | **Atlanta** | **30305** |
| **(Address of principal executive offices)** | **GA** | **(Zip Code)** |

---

**Registrant's telephone number, including area code: (770) 449-0479** 

**Not Applicable**

**Former name or former address, if changed since last report**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class TradingSymbols(s) Name of each exchange on which registered <br> <u>Common Stock</u> <u>CPAY</u> <u>New York Stock Exchange</u>

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 2.01 Completion of Acquisition or Disposition of Assets.**

On November 5, 2025, Corpay, Inc. ("Corpay" or the "Company") filed a Current Report on Form 8-K (the "Original 8-K") with the Securities and Exchange Commission (the "SEC") reporting the completion of its acquisition of Alpha Group International plc ("Alpha"). In order to comply with the rules and regulations promulgated by the Securities and Exchange Commission under the Securities Exchange Act of 1934 and the Securities Act of 1933, the Company hereby amends Item 9.01 of the Original 8-K for the purpose of filing the historical financial statements of Alpha and the related pro forma financial information in accordance with Article 11 of Regulation S-X, which were not previously filed with the Original 8-K.

**Item 9.01 Financial Statements and Exhibits.**

---

| | |
|:---|:---|
| (a) | Financial statements of businesses acquired. |
|  | The audited financial statements of Alpha Group International plc, as of December 31, 2024 and for the year ended December 31, 2024, together with the notes thereto and the independent auditors' report thereon, are filed as Exhibit 99.1 to this Form 8-K/A and incorporated by reference herein.<br>The unaudited financial statements of Alpha Group International plc, as of and for the six months ended June 30, 2025 and 2024 are filed as Exhibit 99.2 to this Form 8-K/A and incorporated by reference herein. |
| (b) | Pro forma financial information. |
|  | The unaudited pro forma condensed combined balance sheet of Corpay, Inc. as of June 30, 2025 and unaudited pro forma condensed combined statements of income of Corpay, Inc. for the year ended December 31, 2024 and the six months ended June 30, 2025 are filed as Exhibit 99.3 to this Form 8-K/A and incorporated by reference herein. |
| (d) | Exhibits |
| <u>[23.1](exhibit231consentofindepen.htm)</u> | Consent of BDO LLP |
| <u>[99.1](ex991alphagroup-financials.htm)</u> | Financial statements of Alpha Group International plc, as of December 31, 2024 and for the year ended December 31, 2024, together with the notes thereto and the independent auditors' report thereon. |
| <u>[99.2](ex992alphagroup-interimrep.htm)</u> | Unaudited Condensed Consolidated Financial Statements, for Alpha Group International plc, as of and for the six months ended June 30, 2025 and 2024. |
| <u>[99.3](ex993corpayproformas.htm)</u> | Unaudited Pro Forma Condensed Combined Financial Information. |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| | Corpay, Inc. |
| February 5, 2026 | *By: /s/ Peter Walker* |
|  | *Peter Walker* |
|  | *Chief Financial Officer* |

---

## Exhibit 23.1

**Exhibit 23.1**

CONSENT OF INDEPENDENT ACCOUNTANTS

Corpay, Inc.

Atlanta, Georgia

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-268238, No. 333-223378, No. 333-190483 and No. 333-171289) of Corpay, Inc. of our report dated February 5, 2026, relating to the consolidated financial statements of Alpha Group International Limited which appears in this Current Report on Form 8K/A. Our report is qualified as to the preparation of consolidated financial statements which omit comparative financial information as of and for the year ended December 31, 2023, which are required to be disclosed in accordance with IAS 1 Presentation of Financial Information. Such application is a departure from International Financial Reporting Standards as issued by the International Accounting Standards Board.

/s/ BDO LLP

BDO LLP

London, United Kingdom

February 5, 2026

## Exhibit 99.1

**Exhibit 99.1**

**Alpha Group International Limited and its subsidiaries**

Consolidated Financial Statements

December 31, 2024

(With Independent Auditors' Report Thereon)

------

**INDEPENDENT AUDITOR'S REPORT** 

Board of Directors

Alpha Group International Limited

London, United Kingdom

**Qualified Opinion** 

We have audited the consolidated financial statements of Alpha Group International Limited and its subsidiaries (the "Company"), which comprise the consolidated statement of financial position as of December 31, 2024 and the related consolidated statements of comprehensive income, changes in equity and cash flows for the year then ended, and the related notes to the consolidated financial statements.

In our opinion, except for the omission of comparative financial information as of and for the year ended December 31, 2023, as described in the Basis for Qualified Opinion section of our report, the accompanying consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and the results of its operations and its cash flows for the year then ended in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board ("IASB").

**Basis for Qualified Opinion** 

The accompanying consolidated financial statements have been prepared by the Company in conformity with International Financial Reporting Standards as issued by the IASB except for the omission of comparative financial information as of and for the year ended December 31, 2023, which are required to be disclosed in accordance with IAS 1, "Presentation of Financial Information". As discussed in Note 2 to the consolidated financial statements, the Company has omitted the presentation of prior period comparatives for the year ended December 31, 2023 which are required by IAS 1, "Presentation of Financial Information", as such comparatives are not required for inclusion in financial statements prepared to fulfil the United States Securities and Exchange Commission reporting requirements under Regulation S-X Rule 3-05.

We conducted our audit in accordance with auditing standards generally accepted in the United States of America (GAAS). Our responsibilities under those standards are further described in the Auditor's Responsibilities for the Audit of the consolidated financial statements section of our report. We are required to be independent of the Company and to meet our other ethical responsibilities, in accordance with the relevant ethical requirements relating to our audit. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our qualified audit opinion.

**Responsibilities of Management for the Financial Statements** 

Management is responsible for the preparation and fair presentation of the consolidated financial statements in accordance with International Financial Reporting Standards as issued by the IASB, and for the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the consolidated financial statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the consolidated financial statements are issued or available to be issued.

**Auditor's Responsibilities for the Audit of the Financial Statements** 

Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with GAAS will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. Misstatements are considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made by a reasonable user based on the consolidated financial statements.

------

In performing an audit in accordance with GAAS, we:

•  Exercise professional judgment and maintain professional skepticism throughout the audit.

•  Identify and assess the risks of material misstatement of the consolidated financial statements, whether due to fraud or error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements.

•  Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control. Accordingly, no such opinion is expressed.

•  Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluate the overall presentation of the consolidated financial statements.

•  Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern for a reasonable period of time.

We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control-related matters that we identified during the audit.

/s/ BDO LLP

BDO LLP

London, United Kingdom

February 5, 2026

------

**Consolidated Statement of Comprehensive Income**

For the year ended 31 December 2024

---

| | | |
|:---|:---|:---|
| | | Year ended<br> 31 December 2024 |
|  | *Note* | £'000 |
| **REVENUE** | *4* | 135600 |
| Net treasury income – client funds | *4* | 83996 |
| Net treasury income – own funds | *4* | 1307 |
| **TOTAL INCOME** |  | 220903 |
| Operating expenses |  | (102608) |
| **OPERATING PROFIT** | *5* | 118295 |
| Finance income | *6* | 6053 |
| Finance expenses | *6* | (1234) |
| **PROFIT BEFORE TAXATION** |  | 123114 |
| Taxation | *8* | (30389) |
| **PROFIT FOR THE YEAR** |  | 92725 |
| Attributable to: |  |  |
| Equity holders of the parent |  | 93019 |
| Non-controlling interests |  | (294) |
| **PROFIT FOR THE YEAR** |  | **92725** |
| **OTHER COMPREHENSIVE (LOSS):** |  |  |
| ***Items that will or may be reclassified to the profit or loss:*** |  |  |
| Exchange loss on translation of foreign operations |  | (2485) |
| (Loss) recognised on hedging instruments |  | (1318) |
| Tax relating to items that may be reclassified |  | 329 |
| **TOTAL COMPREHENSIVE INCOME FOR THE YEAR** |  | **89251** |
| Attributable to: |  |  |
| Equity holders of the parent |  | 89576 |
| Non-controlling interests |  | (325) |
| **TOTAL COMPREHENSIVE INCOME FOR THE YEAR** |  | **89251** |

---

The accompanying notes are an integral part of these Consolidated Financial Statements

------

**Consolidated Statement of Financial Position** 

&nbsp;&nbsp;&nbsp;&nbsp;As at 31 December 2024

---

| | | |
|:---|:---|:---|
|  |  | As at <br>31 December 2024 |
| **NON-CURRENT ASSETS**  | *Note* | £'000 |
| Goodwill | *10, 23* | 4526 |
| Intangible assets | *10, 23* | 14957 |
| Property, plant and equipment | *11* | 7670 |
| Right-of-use assets | *12* | 18993 |
| Derivative financial assets | *14* | 28699 |
| **TOTAL NON-CURRENT ASSETS** |  | 74845 |
| **CURRENT ASSETS** |  |  |
| Cash and cash equivalents | *18* | 252468 |
| Derivative financial assets | *14* | 132446 |
| Trade and other receivables | *17* | 12715 |
| Fixed collateral | *18* | 10063 |
| **TOTAL CURRENT ASSETS** |  | 407692 |
| **TOTAL ASSETS** |  | **482537** |
| <br>**EQUITY** |  |  |
| Share capital | *19* | 87 |
| Share premium account | *19* | 52566 |
| Treasury shares | *19* | (6697) |
| Retained earnings | *19* | 235256 |
| Other reserves | *19* | (3086) |
| **EQUITY ATTRIBUTABLE TO EQUITY HOLDERS OF THE PARENT** |  | 278126 |
| Non-controlling interests |  | 879 |
| **TOTAL EQUITY** |  | 279005 |
| **CURRENT LIABILITIES** |  |  |
| Derivative financial liabilities | *14* | 84080 |
| Other payables | *20* | 45747 |
| Deferred income | *20* | 8059 |
| Lease liability | *12* | 2180 |
| Current tax liability | *8* | 12086 |
| **TOTAL CURRENT LIABILITIES** |  | 152152 |
| **NON-CURRENT LIABILITIES** |  |  |
| Derivative financial liabilities | *14* | 24695 |
| Other payables | *20* | 885 |
| Redemption liability | *23* | 1812 |
| Deferred tax liability | *8* | 3661 |
| Lease liability | *12* | 20327 |
| **TOTAL NON-CURRENT LIABILITIES** |  | 51380 |
| **TOTAL LIABILITIES** |  | 203532 |
| **TOTAL EQUITY AND LIABILITIES** |  | **482537** |

---

The accompanying notes are an integral part of these Consolidated Financial Statements

------

**Consolidated Statement of Cash Flows**

For the year ended 31 December 2024

---

| | | |
|:---|:---|:---|
| | | Year ended 31 December 2024 |
| **CASH FLOWS FROM OPERATING ACTIVITIES** | *Note* | £'000 |
| Profit before taxation |  | 123114 |
| Net treasury income – client funds |  | (83996) |
| Net treasury income – own funds |  | (1307) |
| Finance income | *6* | (6053) |
| Finance expense | *6* | 1234 |
| Amortisation and impairment of intangible assets | *10* | 6598 |
| Depreciation of property, plant and equipment | *11* | 1782 |
| Depreciation of right-of-use assets | *12* | 2793 |
| Loss on disposal of property, plant and equipment | *11* | 224 |
| Gain on disposal of right-of-use asset |  | (93) |
| Share-based payment expense |  | 5325 |
| Increase in other receivables |  | (752) |
| Decrease in other payables |  | (13670) |
| (Increase) in derivative financial assets |  | (53712) |
| Increase in derivative financial liabilities |  | 65149 |
| Increase in fixed collateral |  | (1253) |
| **CASH INFLOWS FROM OPERATING ACTIVITIES** |  | 45383 |
| Net treasury income received |  | 85598 |
| Tax paid |  | (30451) |
| **NET CASH INFLOWS FROM OPERATING ACTIVITIES** |  | 100530 |
| **CASH FLOWS FROM INVESTING ACTIVITIES** |  |  |
| Payments to acquire property, plant and equipment | *11* | (1038) |
| Payments to acquire right-of-use assets |  | (25) |
| Proceeds from the disposal of right-of-use assets |  | 20 |
| Proceeds from sale of property, plant and equipment | *11* | 4 |
| Expenditure on intangible assets | *10* | (7739) |
| Finance income received |  | 6053 |
| **NET CASH OUTFLOWS FROM INVESTING ACTIVITIES** |  | (2725) |
| **CASH FLOWS FROM FINANCING ACTIVITIES** |  |  |
| Issue of treasury shares by Parent Company |  | 303 |
| Purchase of treasury shares | *19* | (30004) |
| Acquisition of non-controlling interest |  | (48) |
| Issue of share options |  | 26 |
| Dividends paid to equity holders of Parent Company | *9* | (7084) |
| Dividends paid to subsidiary shareholders | *9* | (2229) |
| Payment of lease liabilities – principal | *12* | (1065) |
| Payment of lease liabilities – interest | *12* | (1145) |
| **NET CASH OUTFLOWS FROM FINANCING ACTIVITIES** |  | (41246) |
| **INCREASE IN NET CASH AND CASH EQUIVALENTS IN THE YEAR** |  | 56559 |
| Net cash and cash equivalents at beginning of year |  | 197941 |
| Net exchange loss |  | (2032) |
| **NET CASH AND CASH EQUIVALENTS AT END OF YEAR** | *18* | 252468 |

---

The accompanying notes are an integral part of these Consolidated Financial Statements

------

**Consolidated Statement of Changes in Equity**

For the year ended 31 December 2024

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Attributable to the owners of the Parent** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Attributable to the owners of the Parent** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Attributable to the owners of the Parent** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Attributable to the owners of the Parent** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Attributable to the owners of the Parent** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Attributable to the owners of the Parent** | | |
| | <br>Share capital | <br>Share premium account | <br>Treasury shares<br>&nbsp;&nbsp;&nbsp;&nbsp; | <br>Retained earnings | Other reserves  | <br>Total | Non- controlling<br>interests | <br>Total  |
| | **£'000** | **£'000** | **£'000** | **£'000** | **£'000** | **£'000** | **£'000** | **£'000** |
| **Balance at 1 January 2024** | **87** | **52566** | **-** | **170939** | **(632)** | **222960** | **531** | **223491** |
| &nbsp;&nbsp;Profit/(loss) for the year | - | - |  | 93019 |  | 93019 | (294) | 92725 |
| *Other comprehensive expense:* |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Losses recognised on hedging instruments | - | - | - | (989) | - | (989) | - | (989) |
| &nbsp;&nbsp;Exchange differences arising on translation of foreign operations | - | - | - | - | (2454) | (2454) | (31) | (2485) |
| *Transactions with owners:* |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Capital contribution to subsidiary with minority interest | - | - | - | (676) | - | (676) | 676 | - |
| &nbsp;&nbsp;Acquisition of non-controlling interest | - | - | - | (45) | - | (45) | (3) | (48) |
| &nbsp;&nbsp;Acquisition of treasury shares (note 19) | - | - | (10721) | (19283) | - | (30004) | - | (30004) |
| &nbsp;&nbsp;Treasury shares issued in relation to subsidiary earnout (note 19) | - | - | 4024 | - | - | 4024 | - | 4024 |
| &nbsp;&nbsp;Issue of share options in subsidiary undertakings (note 19) | - | - | - | (3721) | - | (3721) | - | (3721) |
| &nbsp;&nbsp;Share-based payments | - | - | - | 5325 | - | 5325 | - | 5325 |
| &nbsp;&nbsp;Dividends paid (note 9) | - | - | - | (9313) | - | (9313) | - | (9313) |
| **Balance at 31 December 2024** | **87** | **52566** | **(6697)** | **235256**  | **(3086)** | **278126** | **879** | **279005** |

---

The accompanying notes are an integral part of these Consolidated Financial Statements

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**1. General information and basis of preparation**

Alpha Group International Limited (the "Company" or "Alpha") is a private company limited by shares. The Company was formerly Alpha Group International plc, a public limited company with shares listed on the Main Market of The London Stock Exchange from 2 May 2024 until 3 November 2025. The Company is incorporated and domiciled in the UK (registered number 07262416) and its registered office is Brunel Building, 2 Canalside Walk, London, England, W2 1DG.

Alpha provides organisations with a high-tech, high-touch suite of cash and risk management solutions. This includes accounts, foreign exchange, debt-sourcing, deposit solutions, and multi-bank connectivity technology, alongside expert advice on managing financial market risks.

Statement of Directors' Responsibilities

The directors are responsible for preparing these special purpose consolidated financial statements for Alpha Group International Limited and its subsidiaries (together, the Group) for the periods presented, in conformity with International Financial Reporting Standards (IFRS), as issued by the International Accounting Standards Board (IASB) with the exception that prior period comparatives for the year ended December 31, 2023 have not been presented, as discussed further below in Note 2 Basis of preparation

The directors are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the group, and for identifying and ensuring that the group complies with the law and regulations applicable to their activities. They are also responsible for safeguarding the assets of the Group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The directors confirm that suitable accounting policies have been used and applied consistently for the periods presented. They also confirm that reasonable and prudent judgements and estimates have been made in preparing the consolidated financial statements, that applicable accounting standards have been followed and that it is appropriate to prepare the financial statements on the going concern basis.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**1. General information and basis of preparation (continued)**

Basis of presentation

These special purpose consolidated financial statements (the "Consolidated Financial Statements") have been prepared by the Directors for inclusion in a filing on Form 8-K/A with the United States Securities and Exchange Commission by Corpay Inc, as a consequence of the acquisition of the Company's issued share capital by Corpay Inc. (see Note 25 Events after the reporting period), for purposes of the satisfaction of Corpay Inc's regulatory reporting requirements in the United States.

These Consolidated Financial Statements do not constitute statutory accounts within the meaning of Section 434 of the United Kingdom Companies Act 2006. The Company prepared statutory consolidated financial statements in accordance with UK adopted international accounting standards for the year ended December 31, 2024, which have been filed with the United Kingdom's Registrar of Companies. Those statutory accounts have been reported on by the Company's independent auditors, BDO LLP, under applicable law and the International Standards on Auditing (United Kingdom). The Independent Auditors' Report of BDO LLP on the Statutory Financial Statements for 2024 was unqualified and did not contain a statement under 498(2) or 498(3) of the United Kingdom's Companies Act 2006.

These Consolidated Financial Statements of Alpha Group International Limited as of 31 December 2024 and for the year then ended were approved by the Board of Directors and authorised for issue on 5 February 2026.

**2. Material accounting policies**

**Basis of preparation** 

The Consolidated Financial Statements have been prepared in accordance with International Financial Reporting Standards ('IFRS') as and issued by the International Accounting Standards Board ('IASB'). with the exception that prior period comparatives for the year ended 31 December 2023 have not been presented as required by IAS 1, "Presentation of Financial Information". Such comparatives have been omitted as they are not required by the SEC in a Form 8-K/A as a consequence of the requirements in Regulation S-X Rule 3-05 Financial statements of businesses acquired or to be acquired. The ability of the Directors to omit prior period comparatives is derived from Regulation S-X Rule 3-05 (b)((2)(ii).

The Consolidated Financial Statements are presented in Pounds Sterling ("£"), and all values are rounded to the nearest thousand ("£'000") except where otherwise indicated. The material accounting policies adopted are set out below and have been applied consistently throughout all periods presented, unless otherwise stated.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**2. Material accounting policies (continued)**

**Basis of preparation (continued)**

The preparation of Consolidated Financial Statements requires the use of certain key accounting estimates. It also requires management to exercise its judgement in the process of applying the Group's accounting policies. The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the Consolidated Financial Statements are disclosed in note 3.

The Consolidated Financial Statements are prepared on the historical cost basis except as detailed below.

**(i) Going concern**

The Board has concluded that it is appropriate to adopt the going concern basis, having undertaken a review of financial forecasts and available resources. The Group meets its day-to-day working capital requirements through its strong cash reserves. As at 31 December 2024, the Group had a healthy liquidity position with £252.5m of cash and cash equivalents (see note 18), with no debt financing commitments. The Group has net current assets of £255.5m at 31 December 2024 and net assets of £279.0m.

In assessing going concern, management have considered some down-side scenarios including decreases in revenue and Net treasury income – client funds and their impact on our profit and cash measures. These scenarios have been modelled on the basis that revenue targets are missed due to an economic downturn, and a fall in NTI due to the uncertain interest rate environment. This assessment considered the impact on the Group's operations, its 2026 budget and internal forecast to 2027.

Even in these scenarios, the Group has strong liquidity, no external debt, and the availability of mitigating actions that would allow it to meet its financial liabilities as they fall due. These mitigating actions, should they be required, are all within management's control and could include limiting new recruitment, reducing variable compensation, and delaying or scaling back investment.

Corpay invested £1.8bn in the acquisition of Alpha, they have publicly committed to supporting the organic growth of Alpha.

Furthermore, Alpha is now part of Corpay and will benefit from access to greater liquidity and funding sources.

The Directors have a reasonable expectation that the Group therefore has adequate resources to continue in operational existence for the foreseeable future. The Group continues to adopt the going concern basis in preparing its Consolidated Financial Statements.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**2. Material accounting policies (continued)**

**Basis of preparation (continued)**

**(ii) New standards, interpretations and amendments effective from 1 January 2024:**

There are no new standards, interpretations and amendments which became mandatorily effective for the current reporting period which have had any material effect on the financial statements of the Group.

**(iii) New standards, interpretations and amendments not yet effective:**

IFRS 18 Presentation and Disclosure in Financial Statements is effective for annual reporting periods beginning on or after 1 January 2027. The Group has not early adopted IFRS 18.

IFRS 18 introduces revised requirements for the presentation and disclosure of financial performance. The Group is currently assessing the potential impact of IFRS 18 on its financial reporting requirements .

No new standards or interpretations have been early adopted.

**Basis of consolidation**

The Consolidated Financial Statements consist of the financial statements of the ultimate Parent Company (Alpha Group International Limited) and all entities controlled by the Company (its subsidiaries).

**(i) Subsidiaries**

Subsidiary undertakings are entities over which the Group has control. Control is defined as the power to direct the entity's relevant activities, exposure to variable returns from involvement with the entity and the ability to use this power to affect the amount of the returns. Subsidiary undertakings are fully consolidated from the date on which control is transferred to the Group. On consolidation intercompany transactions, balances and unrealised gains and losses on transactions between Group entities are eliminated.

**(ii) Acquisition accounting**

Acquisitions are accounted for using the acquisition method, where the purchase price is allocated to the identifiable assets acquired and liabilities assumed on a fair value basis and the remainder recognised as goodwill. The cost of the business combination is measured as the aggregate of the consideration transferred and contingent consideration, measured at fair value on the date of the business combination, and the value of any non-controlling interests in the acquiree.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**2. Material accounting policies (continued)**

**Basis of consolidation (continued)**

On an acquisition-by-acquisition basis, the Group elects whether to measure the non-controlling interests in the acquiree at fair value or at the proportionate share of the acquiree's identifiable net assets.

Where there is an obligation to purchase the non-controlling interest at a future date, a financial liability will be recognised on the business combination.

The financial liability for the non-controlling interest is initially recognised at fair value. The liability is subsequently accounted for under IFRS 9 – Financial Instruments, with all changes in the carrying amount, including the non-controlling interest share of profit, recognised as a re-measurement in the income statement. When the obligation or "put liability" is exercised, the carrying amount of the financial liability at that date is extinguished by the payment of the exercise price. The redemption liability for the fair value of the consideration payable to the non-controlling interest of Financial Transaction Services B.V. (Cobase) is remeasured based on the movement of expected purchase price.

**(iii) Foreign exchange on consolidation**

*Transactions and balances*

<br> Transactions in foreign currencies are initially recorded by the Group entities at the functional currency rates prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated at the functional currency spot rate of exchange ruling at the reporting date. All differences are taken to the Consolidated Statement of Comprehensive Income.

Non-monetary items that are measured at historical cost in a foreign currency are translated using the exchange rates at the date of the initial transaction.

*Group companies*

The results and financial position of Group entities that have a functional currency different from the presentation currency are translated into the presentation currency as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Assets and liabilities at each period end are translated at the prevailing closing rate at the date of the Consolidated Statement of Financial Position;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Income and expenses for each period within the Consolidated Statement of Comprehensive Income are translated at the average rate for the period; and

**(iii) Foreign exchange on consolidation(continued)**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• On consolidation, exchange differences arising from the translation of overseas operations are recognised in other comprehensive income and accumulated in the translation reserve as a separate component of equity. On disposal of a foreign operation, the cumulative translation differences are transferred to the Consolidated Statement of Comprehensive Income as part of the gain or loss on disposal.

**2. Material accounting policies (continued)**

**Financial statement preparation**

**(i) Segmental reporting**

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

In accordance with IFRS 8- Operating Segments, an operating segment is defined as a business activity whose operating results are reviewed by the chief operating decision makers and for which discrete information is available.

Operating segments are reported in a manner consistent with the internal management reporting provided to the chief operating decision-makers. The chief operating decision-makers responsible for allocating resources and assessing performance of the operating segments are identified as the Group's Chief Executive Officer and Chief Financial Officer. More details on the Group's operating segments can be found in note 4.

**(ii) Net treasury income**

'Net treasury income – client funds' (NTI – client funds) is made up of interest generated from client balances. Whilst the increased interest stream is a positive boost for the Group and a natural by-product of our increasingly diversified product offering, we are mindful that aspects of its dynamics are driven by macroeconomics beyond our control. We have therefore chosen to disclose interest income on client balances as 'net treasury income – client funds' separately on the face of the Consolidated Statement of Comprehensive Income.

'Net treasury income – own funds' (NTI – own funds) relates to interest generated within the Corporate division on initial and variation margin balances held by the Group on open trades. The Group has title over these funds and the associated interest earned. The balances on which this interest is earned directly arise from the operations of the business. NTI – own funds is therefore disclosed separately from NTI – client funds.

Interest rate hedging derivatives are taken out to fix the interest rate receivable on client funds and own funds and to hedge against interest rate volatility risk. Payments made to or received from the banking counterparties are shown within NTI – client funds and NTI – own funds respectively. These derivatives are designated as cash flow hedges.

Interest earned on Alpha's own, free cash is recognised within finance income in the Consolidated Statement of Comprehensive Income.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**2. Material accounting policies (continued)**

**Other material accounting policies**

**Revenue**

The Group earns revenue from the provision of risk management and cash management services to clients, and facilitating the flow of payments.

*Risk Management*

When the Group enters into a Risk Management contract with a client, it immediately enters into a separate matched contract with its banking counterparty ("Matched Principle"). Both contracts are derivatives and carried at fair value through profit or loss.

Spot and forward revenue is recognised when a binding contract is entered into by a client and the rate is fixed and determined. Revenue represents the difference between the rate offered to clients and the rate the Group pays its banking counterparties.

Options revenue is recognised when a binding contract is entered into by a client and banking counterparty, and the revenue is fixed and determined. Revenue represents the difference between the premiums paid by clients and the premium the Group pays to its banking counterparties.

*Payments and collections*

Payment and collection services revenue represents the fees and margins generated from both banking and spot transactions. Account fees are generally charged for payments in and out of accounts and account implementation. Revenue in respect of transactional banking fees is recognised when a payment is executed, being the time at which the performance obligation is satisfied.

*Annual account fees*

Revenue from annual account fees is recognised on a straight-line basis over the 12 months from the date the account is opened to the subsequent annual renewal date. This reflects the ongoing access to the account and other ancillary services which are provided to the customer throughout the period the account is open.

*Fund Finance*

Fund Finance provides advisory services to a certain number of our institutional clients who require intermediary services to support their funding requirements. Revenue is recognised in the period in which the advisory work is performed.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**2. Material accounting policies (continued)**

**Other material accounting policies (continued)**

**Revenue (continued)**

*Cobase*

Cobase charge recurring monthly subscription fees for use of their multibank connectivity platform. They also charge implementation fees and costs per user. Revenue from subscription fees and costs per user are recognised monthly in line with the invoicing and platform usage.

Details of the Group's revenue by product along with the classification under IFRS 15 and IFRS 9 can be found in note 4.

**Financial instruments**

***Financial Assets***

*Initial measurement*

All financial assets are measured initially at fair value less transaction costs. The Group's financial assets include derivatives not designated as hedging instruments (forward and option contracts with customers and banking counterparties), derivatives designated as hedging instruments (forward and swap contracts with customers and banking counterparties) and amortised cost assets (financial assets at amortised cost, other receivables, cash and cash equivalents and fixed collateral).

*Subsequent measurement*

IFRS 9 requires the classification of all financial assets to be measured at amortised cost or fair value. Where assets are measured at fair value, gains and losses are recognised in the Consolidated Statement of Comprehensive Income.

The classification of a financial asset is made at the time it is initially recognised, namely when the Group becomes a party to the contractual provisions of the instrument. Following initial measurement, the Group measures its financial assets at fair value through profit or loss or amortised cost, based on the business model for managing the financial instruments and the contractual cash flow characteristics of the instrument.

*Fair value through profit or loss*

This category comprises in-the-money derivatives and out-of-money derivatives where the time value offsets the negative intrinsic value (see "Financial liabilities" section for out-of-money derivatives classified as liabilities). Other than derivative financial instruments which are not designated as hedging instruments, the Group does not have any financial assets at fair value through profit or loss.

*Amortised cost*

The Group's financial assets measured at amortised cost comprise trade and other receivables, cash and cash equivalents and fixed collateral in the Consolidated Statement of Financial Position.

**2. Material accounting policies (continued)**

**Financial instruments (continued)**

***Financial Assets (continued)***

*De-recognition of financial assets*

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

Financial assets will be de-recognised when the contractual rights to the cash flows from the assets have expired, or when the Group transfers its contractual rights to receive the cash flows and substantially all of the risk and rewards of the assets have been transferred.

*Impairment*

An impairment loss is recognised for the amount by which the asset's carrying amount exceeds its recoverable amount. Impairment losses are recognised in the Consolidated Statement of Comprehensive Income. Impairment provisions are recognised under the general approach according to a three-stage expected credit loss impairment model. Financial assets that have not experienced a significant increase in credit risk are categorised as Stage 1 and 12-month expected credit losses are recognised; financial assets which are considered to have experienced a significant increase in credit risk since initial recognition are considered to be Stage 2; and financial assets which have defaulted or are otherwise considered to be credit impaired are allocated to Stage 3. In accordance with IFRS 9, the Group recognises lifetime expected credit losses in respect of trade receivables under the simplified approach.

***Financial liabilities***

*Classification*

The Group determines the classification of its financial liabilities at initial recognition. All financial liabilities are recognised initially at fair value and, in the case of other payables and accruals, subsequently measured at amortised cost. The Group's financial liabilities include derivative financial liabilities, other payables and accruals.

*De-recognition of liabilities*

A financial liability is de-recognised when the obligation under the liability is discharged, substantially modified, cancelled or expires.

***Derivative financial instruments***

The Group undertakes matched principal broking which involves undertaking immediate back-to-back derivative transactions with counterparties. These transactions are classified as financial instruments at fair value through profit or loss and are shown gross unless offset in accordance with the criteria set out below.

**2. Material accounting policies (continued)**

**Financial instruments (continued)**

***Offsetting financial instruments***

When there is a legally enforceable right to offset the recognised amounts and there is an intention to settle on a net basis or realise the asset and settle the liability immediately, financial assets and liabilities are offset, and the net amount reported in the Consolidated Statement of Financial Position.

***Cash and cash equivalents***

Cash and cash equivalents comprise cash balances and deposits held at call with banks. The same definition is used for the purposes of the Consolidated Statement of Cash Flows.

Cash held as collateral with banking counterparties for which the Group does not have immediate access, is shown as fixed collateral, on the face of the Consolidated Statement of Financial Position.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

***Client balances***

Where client balances are held by the Group, as part of its E-Money obligations those funds must be held in segregated accounts, not available for use by the Group, and must comply with UK regulatory safeguarding compliance requirements. The Group is not a party to the contractual provisions nor a beneficial owner of the funds. As a result, the Group has determined that it does not have sufficient ownership or control over these balances to include them and their corresponding liability on the Groups Statement of Financial Position.

**2. Material accounting policies (continued)**

**Financial instruments (continued)**

***Derivative financial instruments and hedge accounting***

The Group uses derivative financial instruments to hedge interest rate risk on treasury income receivable, and where denominated in foreign currency, exchange rate risk.

All derivative financial instruments are initially measured at fair value on the contract date and also at subsequent reporting dates.

Hedge accounting is applied to financial assets and financial liabilities only where all of the following criteria are met:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The hedging relationship consists only of eligible hedging instruments and eligible hedged items.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• At the inception of a hedge there is formal designation and documentation of the hedging relationship, the Group's risk management objective and strategy for undertaking the hedge, the hedged item and hedging instrument, and how the hedge effectiveness will be assessed;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• An economic relationship exists between the hedged item and the hedging instrument;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Credit risk does not dominate changes in value; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The hedge ratio is the same for both the hedging relationship and the quantity of the hedged item actually hedged and the quantity of the hedging instrument used to hedge it.

If derivatives do not qualify for hedge accounting, any changes in the fair value of the derivative financial instrument are recognised in the Consolidated Statement of Comprehensive Income as they arise.

Hedge relationships are classified as cash flow hedges where the derivative financial instruments hedge the Group's exposure to variability in cash flows resulting from a highly probable transaction.

Hedge effectiveness checks are carried out routinely. Changes in the fair value of derivative financial instruments that are designated and effective as hedges of future cash flows are recognised directly in other comprehensive income and any ineffective portion would be recognised immediately in the income statement. Hedge ineffectiveness can arise from changes in credit risk of the banking counterparty or from cash balances falling below the notional amounts hedged. If the hedging derivative expires or is sold, terminated, or exercised, or the hedge no longer meets the criteria for hedge accounting, or the hedge designation is revoked, hedge accounting is discontinued prospectively.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**2. Material accounting policies (continued)**

**Fair value**

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

The Group uses valuation techniques that are appropriate to the circumstances and for which sufficient data is available to measure fair value, maximising the use of relevant observable inputs and minimising the use of unobservable inputs.

All assets and liabilities for which fair value is measured or disclosed in the financial statements are categorised within the fair value hierarchy, described as follows, based on the lowest level input that is significant to the fair value measurement as a whole:

-Level 1 &nbsp;&nbsp;&nbsp;&nbsp;quoted (unadjusted) market prices in active markets for identical assets or liabilities.

-Level 2&nbsp;&nbsp;&nbsp;&nbsp;valuation techniques for which the lowest level input that is significant to the fair value measurement is directly or indirectly observable.

-Level 3&nbsp;&nbsp;&nbsp;&nbsp;valuation techniques for which the lowest level input that is significant to the fair value measurement is unobservable.

For the purpose of fair value disclosures, the Group has determined classes of assets and liabilities based on the nature, characteristics and risks of the inputs into the valuations and the level of the fair value hierarchy as explained above.

The Group performs an assessment of fair value on an ongoing basis by as assessing counterparty credit risk via the credit value adjustment model (see further details in note 3).

**Share-based payments** 

The Group issues equity-settled share-based payments to Directors and employees of the Group through the Growth Share Schemes, Approved and Unapproved Options Schemes and Group Incentive Plan schemes.

Equity-settled share-based schemes are measured at fair value, excluding the effect of non-market-based vesting conditions, at the date of grant using an appropriate option pricing model. All share schemes are valued using a Monte Carlo Simulation Approach. The Growth Share Schemes and Group Incentive Plan schemes have market-based conditions and non-market-based conditions which exist over revenue-based targets, requiring management to estimate the probability of meeting these conditions. The Underlying Profit After Tax Share Schemes do not have market-based conditions. All schemes require the estimation of appropriate attrition rates to estimate the number of share options which are likely to vest.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**2. Material accounting policies (continued)**

**Share-based payments (continued)**

The fair value of the shares or share options less the subscription price payable by the employees is recognised over the vesting period to reflect the value of the employee services received. The charge relating to grants to employees of the Company is recognised as an expense in the Consolidated Statement of Comprehensive Income.

**Property, plant and equipment**

*Owned assets*

Property, plant and equipment is stated at cost less accumulated depreciation and where applicable, impairment losses.

*Depreciation*

Depreciation is charged to the Consolidated Statement of Comprehensive Income on a straight-line basis over the estimated useful lives of each item of property, plant and equipment.

The estimated useful lives of property, plant and equipment are as follows:

---

| | | |
|:---|:---|:---|
| Improvements to property | - | Period of lease, straight line |
| Fixtures and fittings | - | 4 to 5 years straight line |
| Computer equipment | - | 3 years straight line |

---

**Intangible assets**

Intangible assets not acquired in a business combination consist of internally developed software and domain names.

Expenditure on internally developed software is capitalised if the costs can be reliably measured, the product or process is technically and commercially feasible, future economic benefits are probable, and the Group has sufficient resources to complete the development and to use or sell the asset. The assets are initially recorded at cost including labour, directly attributable costs and any third-party expenses, and amortised over their useful economic lives of 3 years from the date of first use.

Intangible assets acquired in a business combination are identified and recognised separately from goodwill where they satisfy the definition of an intangible asset and their fair values can be measured reliably. The cost of such intangible assets is their fair value at the acquisition date.

**2. Material accounting policies (continued)**

**Intangible assets (continued)**

Subsequent to initial recognition, intangible assets acquired in a business combination are reported at cost less accumulated amortisation and accumulated impairment losses.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

The estimated useful lives of intangible assets are as follows:

---

| | | |
|:---|:---|:---|
| Internally generated software and Domain names | - | 3 years straight line |
| Software obtained through acquisition | - | 3 years straight line |
| Brand | - | 10 years straight line |
| Customer relationships | - | 14 years straight line |

---

**Leases**

In accordance with IFRS 16 Leases, the Group recognises a right-of-use asset and corresponding liability at the date at which the leased asset is available for use.

Right-of-use assets are recorded initially at cost and amortised on a straight-line basis over the lease term. Cost is defined as the net present value of the lease liabilities, plus any initial costs and dilapidation provisions, less any lease incentives received. The right-of-use asset is tested for impairment if there are any indicators of impairment.

The lease liability is measured at the present value of the lease payments, discounted at the rate implicit in the lease, or if that cannot be readily determined, at the lessee's incremental borrowing rate specific to the term, country, currency and start date of the lease.

The finance cost is charged to the Consolidated Statement of Comprehensive Income over the lease period so as to produce a constant periodic rate of interest on the remaining balance of the liability for each period.

**Sales commissions**

Sales commissions are recognised as an expense in the period in which the revenue is generated and paid in arrears.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**2. Material accounting policies (continued)**

**Taxes**

*Current income tax*

Current income tax assets and liabilities are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted at the reporting date.

*Deferred income tax*

Deferred income tax is provided on all temporary differences at the reporting date arising between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset realised, based on the tax rates that have been enacted or substantively enacted by the balance sheet date.

Recognition of deferred tax assets is restricted to those instances where it is probable that taxable profit will be available against which the difference can be utilised.

Deferred tax assets and liabilities are offset when the Group has a legally enforceable right to offset current tax assets liabilities, and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

**Business combinations**

Goodwill arising on the acquisition of subsidiaries represents the excess of the cost over the fair value of the identifiable net assets acquired at the date of the acquisition and is carried at cost less any accumulated impairment losses.

Goodwill is not subject to amortisation but is tested annually for impairment. Impairment is determined by assessing the recoverable amount of the cash generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the Group are assigned to those units.

*Fair value of acquired intangible assets – 2023 Cobase acquisition*

The fair value of acquired intangible assets, and therefore the resulting goodwill recognised on acquisition is significantly affected by a number of factors. These include management's best estimates of future performance including forecast revenue, expected revenue attrition, forecast operating margin, any contributory assets changes, and estimates of the return required to determine an appropriate discount rate (in order to calculate the net present value of the assets at acquisition).

**3. Significant accounting estimates and judgements**

The preparation of the Group's financial statements requires management to make estimates, judgements and assumptions about the carrying amounts of assets and liabilities. Uncertainty about these assumptions and estimates could result in outcomes that could require a material adjustment to the carrying amount of the assets or liability affected in the future.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

The estimates and underlying assumptions are reviewed on an ongoing basis. In the process of applying the Group's accounting policies, management has made the following judgements and estimates which have the most significant effect on the amounts recognised in the Consolidated Financial Statements.

**Significant estimates**

***Impairment of financial assets***

An impairment loss is recognised for the amount by which the asset's carrying amount exceeds its recoverable amount. Impairment losses are recognised in the Consolidated Statement of Comprehensive Income. The Group performs an assessment of significant increase in credit risk on an annual basis, as well as assessing counterparty credit risk on an ongoing basis via the credit value adjustment model.

***Fair value - Credit valuation adjustment***

The credit value adjustment of £4.4m has been calculated by management based on the assumption that the Group will be unable to collect all the receivable amounts due under the contract terms, and therefore, is a method of counterparty credit risk management. In order to calculate expected future cash flows, management make an estimate using the latest real-time market information, forward-looking volatility, credit quality of the borrower, and experience.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**3. Significant accounting estimates and judgements (continued)**

**Significant judgements**

***Development costs***

Development costs that are directly attributable to the development of a project are capitalised based on management's assessment of the likelihood of a successful outcome for each project. This is based on the management's judgement that the project is technologically, commercially and economically feasible in accordance with IAS 38 Intangible Assets. In determining the amount to be capitalised, management makes assumptions regarding the expected future cash generation of the project, i.e. Group revenue, and the expected period of benefits.

***Share-based payments- Option fair values***

As described in note 2, equity settled share awards are recognised as an expense based on their fair value at date of grant. The fair value of these share option schemes are estimated through the use of option valuation models which require an element of judgement in assessing the inputs. Judgement is also exercised in assessing the number of options subject to non-market vesting conditions that will vest. Further details are set out in note 22.

***Carrying value of goodwill attributable to Cobase – estimation of recoverable amount***

Goodwill of £4.7m arose on the acquisition of Financial Transaction Services B.V., trading as "Cobase" (see note 23), and is tested for impairment annually. Recoverable amount has been assessed based on estimates of the fair value less cost to sell. In making this determination, management has estimated the appropriate range of market multiples to be applied to Cobase. Further details are set out in note 10.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**4. Segmental reporting**

The Group comprises three operating segments which are Corporate, Private Markets and Cobase. These align with the management accountabilities for performance management and the basis for internal financial reporting and represent our reportable segments. These three segments are explained further as below:

**Corporate:** Alpha's corporate division operates from its own UK HQ (consisting of sales and operations), and seven additional international sales offices in the Netherlands, Spain, Italy, Germany, Austria, Australia, and Canada. Revenues are derived from the provision of market risk management services to corporates across more than 50 countries, covering foreign exchange exposure and, more recently, interest rates and commodities.

**Private Markets:** Alpha's private markets division operates from its own UK HQ (consisting of sales and operations) and two additional operations offices in Luxembourg and Malta. Revenues are derived from the provision of FX risk management, accounts and payments, and fund finance services to private market firms.

**Cobase:** Cobase is a treasury-focused technology platform acquired by the Group in December 2023. Based in Amsterdam, the company provides bank connectivity technologies that enable businesses to manage their banking relationships, accounts and transaction activity all in one place. Revenues are derived from platform usage and annual subscription fees.

The chief operating decision makers, being the Group's Chief Executive Officer and the Chief Financial Officer, monitor the results of the three operating segments separately each month. Key measures of operating segments used to evaluate performance are revenue, and underlying profit before taxation. Management believe that these measures are the most relevant in evaluating the performance of the segment and for making resource allocation decisions.

The Group has disclosed revenue for each segment disaggregated between Risk Management, Accounts & payments and platform fees, to assist users in understanding the product mix. All costs are attributed to these segments.

'Net treasury income – own funds' relates to interest earned on client margin held by the Corporate division and is incorporated in the definition of underlying profit for that business as this income is a direct consequence of operational activities.

The Corporate division has overseas offices in Australia, Canada, Netherlands, Italy, Spain and Germany. In 2024, these offices contributed aggregate revenue of £27.2m and underlying profit before taxation of £6.6m. A small component of Private Markets costs arise in Luxembourg, and the profit related to the Malta office has been allocated between the various European entities it supports.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**4. Segmental reporting (continued)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **2024** | <br>Corporate  | <br>Private Markets | <br>Cobase | <br>Total |
|  | £'000 | £'000 | £'000 | £'000 |
| Risk Management\* | 63759 | 28344 | - | 92103 |
| Accounts & payments\*\*<br>Platform fees | -<br>- | 40610<br>- | -<br>2887 | 40610<br>2887 |
| **Total revenue** | **63759** | **68954** | **2887** | **135600** |
| Net Treasury Income - own funds<br>**Segment income** | 1307<br>**65066** | -<br>**68954** | -<br>**2887** | 1307<br>**136907** |
| Operating costs | (39261) | (49893) | (5197) | (94351) |
| **Underlying operating profit** | **25805** | **19061** | **(2310)** | **42556** |
| <br>Finance Income<br>Finance expense | <br>6016<br>(457) | <br>37<br>(777) | <br>-<br>- | <br>6053<br>(1234) |
| **Underlying profit before taxation** | **31364** | **18321** | **(2310)** | **47375** |
| <br>Net treasury income - client funds | <br>4059 | <br>79937 | <br>- | <br>83996 |
| Non-underlying items\*\*\* |  |  |  | (8257) |
| **Profit before taxation** |  |  |  | **123114** |

---

\*Risk Management represents revenue derived from forward, spot, and option contracts provided to corporate and private market clients, primarily for the purpose of hedging commercial foreign exchange exposures.

\*\*Accounts & payments represents revenues derived from fees and foreign exchange spot contracts

generated from the provision of cross border payments, collections and annual account fees to corporates and private markets, as well as Fund Finance advisory fees.

\*\*\*Non-underlying items in the year are made up of the below charges:

---

| | |
|:---|:---|
|  | <br>31 December 2024 |
|  | £'000 |
| Acquisition costs in relation to business combinations | 104 |
| Costs associated with the move from AIM to the Main Market | 2746 |
| Amortisation of purchased intangible assets | 82 |
| Share-based payments charge | 5325 |
| **Total non-underlying items** | 8257 |

---

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**4. Segmental reporting (continued)**

All revenue is derived from external customers and is determined by the geographical location of those customers.

No customer represents more than 10% of revenue and the Group does not believe there is undue reliance on any specific sub-set of customers.

---

| | |
|:---|:---|
| **Revenue by region of customer** | 31 December 2024<br>£'000 |
| United Kingdom | 43578 |
| Europe | 68847 |
| Canada | 4389 |
| Rest of the world | 18786 |
| **Total** | **135600** |

---

---

| | |
|:---|:---|
| **Revenue by product** | 31 December 2024<br>£'000 |
| Forward transactions | 63268 |
| Spot transactions | 32590 |
| Option contracts | 11650 |
| Payments, accounts and advisory fees | 25205 |
| Platform fees | 2887 |
| **Total** | **135600** |

---

Forward, spot and option revenues are accounted for under IFRS 9 - Financial Instruments, and the remaining revenue streams i.e. payments, accounts, advisory and platform fees fall under IFRS 15 - Revenue from Contracts with Customers.

The table below discloses non-current assets (excluding financial instruments and deferred tax) by location:

---

| | |
|:---|:---|
| <br>**Non-current assets** | 31 December 2024<br>£'000 |
| United Kingdom | 26879 |
| Malta | 6068 |
| The Netherlands | 10454 |
| Canada | 1032 |
| Other | 1713 |
| **Total non-current assets** | **46146** |

---

No information is provided for segment assets or segment liabilities as this measure is not reported to the chief operating decision makers.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**5. Operating profit**

Operating profit is stated after charging/(crediting):

---

| | |
|:---|:---|
|  | 31 December 2024 |
|  | £'000 |
| Staff costs (note 7) | 56596 |
| Depreciation of owned property, plant and equipment | 1782 |
| Amortisation of intangible assets\* | 6595 |
| Depreciation of right-of-use assets | 2793 |
| Rental costs for short-term leases | 1022 |
| Loss on disposal of fixed assets | 224 |
| Gain on disposal of right-of-use asset | (93) |
| Impairment of intangible assets | 3 |
| Bad debt expense | 508 |
| Net foreign exchange (gains) | (409) |
| *Audit fees* |  |
| Audit fees in respect of the Group, Company and subsidiary financial statements | <br>896  |
| *Non-Audit fees* |  |
| Fees in respect of CASS Limited Assurance | 10 |
| Fees associated with the move from AIM to the Main Market<sup>1</sup> | 498 |

---

\*Amortisation of intangible assets includes a charge of £6,513k relating to internally generated software and a charge of £82k relating to brand and customer relationships.

**6. Finance income and expenses**

---

| | |
|:---|:---|
| | 31 December 2024 |
| | £'000 |
| **Finance income** |  |
| Interest on bank deposits | 5945 |
| Other interest receivable | 108 |
| **Total** | **6053** |
| **Finance expenses** |  |
| Finance expense on dilapidation provisions | (34) |
| Finance expense on lease liabilities (note 12) | (1200) |
| **Total** | **(1234)** |

---

<sup>1</sup> Alternative Investment Market ('AIM') is the London Stock Exchange's junior market for smaller, high-growth companies with lighter regulations, while the Main Market hosts larger, more established firms requiring strict adherence to stringent listing rules.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**7. Employee costs**

Staff costs, including Directors' remuneration, were as follows:

---

| | |
|:---|:---|
| | 31 December 2024<br>£'000 |
| Wages and salaries | 45293 |
| Social security costs | 5096 |
| Share-based payment charge | 5325 |
| Other pension costs | 882 |
| **Employee benefit expense included in operating profit** | **56596** |

---

During the year 2024, the research and development expenditure credit (RDEC) of £393,503 was offset against employee costs.

The average number of employees, including the Executive Directors, was as follows:

---

| | |
|:---|:---|
| | 31 December <br>2024 |
| | 31 December <br>2024 |
| | No. |
| Executive Directors | 3 |
| Sales, administration and support staff | 521 |
| **Total** | **524** |

---

**Remuneration of key management personnel**

Key management personnel represent those personnel who have authority and responsibility for planning, directing and controlling the activities of the Group, including Non-Executive Directors who served during the year. There were 12 individuals classified as key management personnel in the Group in 2024.

Key management remuneration and benefits include:

---

| | |
|:---|:---|
| | 31 December<br> 2024 |
| | 31 December<br> 2024 |
| | £'000 |
| Wages and salaries | 3983 |
| Social security costs | 526 |
| Share-based payments | 1085 |
| Defined contribution scheme | 32 |
| **Total** | 5626 |

---

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**7. Employee costs (continued)**

Share-based payments in the above table comprise the aggregate amount of gains by directors on the exercise of share options in the year, being the difference between the market price of the shares on the day on which the options exercised, and the price paid for the shares.

During 2024, retirement benefits in respect of defined contribution pension schemes accrued to 10 individuals who are regarded as key management personnel.

**8. Taxation** 

 **Tax charge**

---

| | |
|:---|:---|
| | 31 December 2024 |
| | 31 December 2024 |
| | £'000 |
| **Current tax:** |  |
| UK Corporation tax on the profit for the year | 31172 |
| Adjustments relating to prior years | (215) |
| Overseas corporation tax on the profit for the year | 744 |
| **Total current tax** | 31701 |
| **Deferred tax** |  |
| Origination and reversal of temporary differences current year | (427) |
| Adjustment relating to prior year | (885) |
| **Total deferred tax** | (1312) |
| **Total tax expense** | 30389 |

---

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**8. Taxation (continued)**

**Factors affecting tax charge for the year**

---

| | |
|:---|:---|
| | 31 December 2024<br>£'000 |
| Profit on ordinary activities before tax | 123114 |
| Profit on ordinary activities multiplied by the effective standard rate of UK corporation tax of 25% | 30779 |
| Effects of: |  |
| Expenses not deductible for tax purposes | 610 |
| Unutilised trading losses different tax rates applied in overseas jurisdictions | 44 |
| Adjustments relating to prior years | (1101) |
| Deferred tax not recognised on losses unutilised | 57 |
| **Total tax charge for the year** | 30389 |

---

During the year, management identified that a £1.1m deferred tax liability recognised at 31 December 2023 in relation to the Cobase business had been overstated and the charge has been corrected in the current year. In addition, the Group has recognised a deferred tax asset of £0.4m in respect of future tax deductions for the amortisation of customer lists in Malta. This asset is expected to be amortised over the next two years.

**Deferred tax**

The deferred taxation liability is based on the expected future rate of corporation tax of 25% and comprises the following:

---

| | |
|:---|:---|
| | 31 December 2024<br>£'000 |
| **Liabilities** |  |
| At 1 January | 5305 |
| UK & overseas tax charge relating to current year from continuing operations | (343) |
| UK tax charge relating to current year from acquired operations | (971) |
| Tax (credit) on other comprehensive income | (330) |
| **Total deferred tax liability** | 3661 |

---

The UK deferred tax liability as at 31 December 2024 principally relates to the tax effect of timing differences in respect of fixed assets.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**8. Taxation (continued)**

**Deferred Tax – Balance**

---

| | |
|:---|:---|
| | 31 December 2024<br>£'000 |
| **Liabilities** |  |
| Fixed asset differences | 3890 |
| Right-of-use assets | 2 |
| Losses | (115) |
| Future tax deductions for amortisation of customer lists in Malta | (405) |
| Gain recognised on hedging instruments | 289 |
| **Total deferred tax liability** | 3661 |

---

Losses of €28m (tax effect €4.4m) arose for periods prior the 2023 acquisition of Financial Transaction Services B.V. (Cobase). Under Dutch tax regulations these losses can be carried forward indefinitely but are only available for offset against a limited portion of profits in any given year. Based on the latest forecasts, no material losses are expected to be utilised in the near term and accordingly no deferred tax asset has been recognised. Losses in other jurisdictions carried forward for which no deferred tax asset has been recognised total £0.14m.

Deferred tax on each component of other comprehensive (expense) is as follows:

---

| | | | |
|:---|:---|:---|:---|
| 31 December 2024 | Before tax | Tax | After tax |
|  | £'000 | £'000 | £'000 |
| ***Cash flow hedges*** |  |  |  |
| (Losses) recognised on hedging instruments | (1318) | 329 | (989) |
| Exchange loss arising on translation of foreign operations | (2485) | - | (2485) |
| **Total tax (charge) on other comprehensive (expense)** | (3803) | 329 | (3474) |

---

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**9. Dividends**

---

| | |
|:---|:---|
| | 31 December 2024 |
| | £'000 |
| Final dividend for the year ended 31 December 2023 of 12.3p per share | 5308 |
| Interim dividend for the year ended 31 December 2024 of 4.2p per share | 1776 |
|  | 7084 |

---

All dividends paid by Alpha Group International Limited are in respect of the ordinary shares of £0.002 each.

In addition to the dividends paid to ordinary shareholders of the Group shown above, the Consolidated Statement of Changes in Equity includes £2,229k of dividends paid to subsidiary shareholders. See note 13 for further details.

For details of the Final dividend for the year ended 31 December 2024, refer to note 25.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**10. Intangible assets**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Goodwill\*** | **Software** | **Domain names** | **Brand** | **Customer relationships** | **Total** |
| | £'000 | £'000 | £'000 | £'000 | £'000 | £'000 |
| **Cost** |  |  |  |  |  |  |
| At 1 January 2024 | 4707 | 16660 | 62 | 542 | 438 | 22409 |
| Additions | - | 7739 | - | - | - | 7739 |
| Impairment | - | (1603) | (37) | - | - | (1640) |
| Foreign exchange translation | (181) | (209) | - | (21) | (17) | (428) |
| **At 31 December 2024** | **4526** | **22587** | **25** | **521** | **421** | **28080** |
| **Amortisation** |  |  |  |  |  |  |
| At 1 January 2024 | - | 3641 | 47 | 5 | 2 | 3695 |
| Charge for year | - | 6502 | 11 | 52 | 30 | 6595 |
| Impairment | - | (1600) | (37) | - | - | (1637) |
| Foreign exchange translation | - | (56) | - | - | - | (56) |
| **At 31 December 2024** | **-** | **8487** | **21** | **57** | **32** | **8597** |
| **Net book value** |  |  |  |  |  |  |
| At 1 January 2024 | 4707 | 13019 | 15 | 537 | 436 | 18714 |
| **At 31 December 2024** | 4526 | 14100 | 4 | 464 | 389 | 19483 |

---

\*Goodwill of £4.7m arose on the acquisition of Financial Transaction Services B.V. (trading as "Cobase") (see note 23), and has been fully allocated to the Cobase operating segment. Management performed an impairment test by comparing the carrying value of the Cobase CGU against its recoverable amount, based on fair value less costs of disposal. The fair value less cost of disposal was determined with reference to a range of relevant market multiples for specific SAAS businesses in the banking technology sector comparable to Cobase, sourced from independent market reports, and considering them in conjunction with Cobase's actual revenue realisation to date, budgeted revenue for 2025 and annual recurring revenue ("ARR") as at 31 December 2024. The model is categorised within Level 3 of the fair value hierarchy as set out in note 2. The review considered a range of scenarios, all of which indicate fair value less cost of disposal is comfortably in excess of the carrying amount.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**11. Property, plant and equipment**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Leasehold improvements** | **Fixtures & fittings** | **Computer equipment** | <br>**Total** |
| | £'000 | £'000 | £'000 | £'000 |
| **Cost** |  |  |  |  |
| **At 1 January 2024** | **7401** | **2376** | **1995** | **11772** |
| Additions | 484 | 132 | 422 | 1038 |
| Disposals | (317) | (85) | (5) | (407) |
| Foreign exchange translation | (150) | (33) | (22) | (205) |
| **At 31 December 2024** | **7418** | **2390** | **2390** | **12198** |
| **Depreciation** |  |  |  |  |
| **At 1 January 2024** | **1086** | **819** | **1067** | **2972** |
| Charge for the year | 828 | 424 | 530 | 1782 |
| Disposals | (142) | (38) | (3) | (183) |
| Foreign exchange translation | (23) | (9) | (11) | (43) |
| **At 31 December 2024** | **1749** | **1196** | **1583** | **4528** |
| **Net book value** |  |  |  |  |
| At 1 January 2024 | 6315 | 1557 | 928 | 8800 |
| **At 31 December 2024** | **5669** | **1194** | **807** | **7670** |

---

&nbsp;&nbsp;&nbsp;&nbsp;

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**12. Right-of-use assets and lease liabilities**

Leases where the Group is a lessee are accounted for by recognising a right-of-use asset and a lease liability except for leases of low value assets and leases with a term of 12 months or less. The Group has only property leases.

During the year, the Group signed two new leases for office premises in Italy and Australia. The Group exited a lease early in Bristol and recognised a gain on disposal of £92,822 (see note 5).

**Right-of-use assets**

---

| | |
|:---|:---|
| | 31 December 2024 |
| | £'000 |
| At 1 January | 20894 |
| Additions | 1347 |
| Depreciation charge for the year | (2793) |
| Disposals | (164) |
| Foreign exchange translation | (291) |
| At 31 December | 18993 |

---

**Lease liabilities**

---

| | |
|:---|:---|
| | 31 December 2024 |
| | £'000 |
| At 1 January | 22720 |
| Additions | 1288 |
| Disposals | (194) |
| Finance cost (note 6) | 1200 |
| Payments in the year | (2210) |
| Foreign exchange translation | (297) |
| At 31 December | 22507 |

---

---

| | |
|:---|:---|
| | 31 December 2024 |
| | £'000 |
| Maturity analysis: |  |
| Not later than 1 year | 2180 |
| Later than 1 year and not later than 5 years | 10661 |
| Later than 5 years | 9666 |
| Total lease liabilities | 22507 |

---

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**12. Right-of-use assets and lease liabilities (continued)**

**Lease liabilities (continued)**

---

| | |
|:---|:---|
| | 31 December 2024 |
| | £'000 |
| Analysis: |  |
| Current | 2180 |
| Non-current | 20327 |
| Total lease liabilities | 22507 |

---

The total undiscounted payments committed to over the remaining useful life of the respective leases as of the end of 31 December 2024 amounted to £27,605,601.

**Amounts recognised in the Consolidated Statement of Comprehensive Income** 

**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**

---

| | | |
|:---|:---|:---|
| | | 31 December 2024 |
| | | £'000 |
| Depreciation charge on right-of-use assets (note 5) | Depreciation charge on right-of-use assets (note 5) | 2793 |
| Interest on lease liabilities (note 6) | Interest on lease liabilities (note 6) | 1200 |
| Rental costs for short-term leases (note 5) | Rental costs for short-term leases (note 5) | 1022 |
| Total | **5015** | **5015** |

---

The rental costs for short-term leases amounting to £1,022,363 relate to leases of less than one year for premises for a number of the Group's overseas offices.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**13. Subsidiaries** 

The Group's subsidiaries as at 31 December 2024 are as follows:

---

| | | | |
|:---|:---|:---|:---|
| <br>**Name** | <br>**Country of incorporation** | <br>**Proportion of ordinary shares held** | |
| **Direct Holding** | | | |
| Alpha FX Limited | England<sup>1</sup>  | 100% | Active |
| Alpha Agency Solutions Ltd | England<sup>1</sup> | 100% | Active |
| Financial Transaction Services B.V. | Netherlands<sup>6</sup> | 86.87% | Active |
| <br>**Indirect Holding** |  |  |  |
| Alpha FX Institutional Limited | England<sup>1</sup> | 100% | Active |
| Alpha Foreign Exchange (Canada) Limited | Canada<sup>2</sup> | 100% | Active |
| Alpha FX Netherlands Limited | England<sup>1</sup> | 100% | Active |
| Alpha FX Europe Limited | Malta<sup>3</sup> | 100% | Active |
| Alpha FX Australia Pty Ltd | Australia<sup>4</sup> | 100% | Active |
| AGI Financial PTE. Ltd. | Singapore<sup>5</sup> | 100% | Non-trading |

---

**Registered addresses:**

1. Brunel Building, 2 Canalside Walk, London, UK, W2 1DG

2. Suite 2400, 745 Thurlow Street, Vancouver BC, V6E0C5, Canada

3. 171, Old Bakery Street, Valletta VLT1455, Malta

4. c/o Intertrust Australia Pty Ltd, Suite 2, Level 25, 100 Miller Street, North Sydney, NSW 2060

5. 14 Robinson Road #12-01/02, Far East Finance Building, Singapore (048545)

6. Haaksbergweg 75, 1101BR Amsterdam

The principal activity of the Group and its subsidiary undertakings is the development of financial strategies and technologies to assist corporates and private market organisations in their risk management, mass payments and account opening requirements. The accounting year-ends of all subsidiaries is 31 December.

Shares in all indirect subsidiary holdings are held by Alpha FX Limited. In addition, certain employees also own interests in indirect subsidiaries through shares of a separate class which were issued on granting of awards under certain share-based payment schemes as set out in note 22. These shares confer dividend rights over the duration of the share scheme performance period, but confer no other ownership interest, and on vesting will convert to shares in the parent company, to the extent vesting criteria are met at which point the subsidiary shares are paid for.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**13. Subsidiaries (continued)**

In accordance with IFRS 2 Share-Based Payment, share ownership schemes that grant employees shares or options in subsidiaries, with conversion rights to the holding company should be accounted for under IFRS 2, rather than a non-controlling interest in a subsidiary. Accordingly, we disclose the Group as holding 100% of the ordinary shares in these entities. Dividends paid to employees as a result of their share ownership under these arrangements are disclosed as dividends paid to subsidiary shareholders in the Consolidated Statement of Cash Flows.

In October 2024 Alpha FX Italy Limited was dissolved and transferred to a branch of Alpha FX Europe Limited.

In December 2023 86.36% of Financial Transaction Services B.V. (trading as Cobase) was acquired as part of a business combination (see note 23). In August 2024 Alpha acquired a further 0.51% for a consideration of €56,495 as a result of a non-controlling interest selling shares in the subsidiary bringing Alpha's holding to 86.87%.

As set out in Note 25, subsequent to the year end, the remaining non-controlling interest in Cobase was acquired in October 2025.

**14. Derivative financial assets and financial liabilities**

---

| | | |
|:---|:---|:---|
| | 31 December 2024 | 31 December 2024 |
| **Derivative financial assets not designated as hedging instruments** | <br>Fair value | Notional principal |
|  | £'000 | £'000 |
| Forward and option contracts with customers | <br>156570 | <br>4332514 |
| Forward and option contracts with banking counterparties | <br>1634 | <br>140240 |
| <br>Other forward contracts | <br>842 | <br>54074 |
|  | 159046 | 4526828 |

---

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**14. Derivative financial assets and financial liabilities (continued)**

---

| | | |
|:---|:---|:---|
| | 31 December 2024 | 31 December 2024 |
| **Derivative financial assets designated as hedging instruments** | <br>Fair value | Notional<br>Principal |
|  | £'000 | £'000 |
| Forward contracts | - | - |
| Swap contracts | 2099 | 699831 |
|  | 2099 | 699831 |

---

---

| | | |
|:---|:---|:---|
| | 31 December 2024 | 31 December 2024 |
| **Total Derivative financial assets** | <br>Fair value | Notional<br>Principal |
|  | £'000 | £'000 |
|  | 161145 | 5226659 |

---

---

| | |
|:---|:---|
| | 31 December 2024 |
| | Fair value |
| Analysis: | £'000 |
| Current | 132446 |
| Non-current | 28699 |
| Total derivative financial assets | 161145 |

---

---

| | | |
|:---|:---|:---|
| | 31 December 2024 | 31 December 2024 |
| **Derivative financial liabilities not designated as hedging instruments** | <br>Fair value | Notional<br>Principal |
|  | £'000 | £'000 |
| Forward and option contracts with customers | <br>98839 | <br>3771123 |
| Forward and option contracts with banking counterparties | <br>9073 | <br>2553445 |
| Other forward contracts | - | - |
|  | 107912 | 6324568 |

---

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**14. Derivative financial assets and financial liabilities (continued)**

---

| | | |
|:---|:---|:---|
| | 31 December 2024 | 31 December 2024 |
| **Derivative financial liabilities designated as hedging instruments** | <br>Fair value | Notional<br>Principal |
|  | £'000 | £'000 |
| Forward contracts | - | - |
| Swap contracts | 863 | 355000 |
|  | 863 | 355000 |

---

---

| | | |
|:---|:---|:---|
| | 31 December 2024 | 31 December 2024 |
| **Total Derivative financial liabilities** | <br>Fair value | Notional<br>Principal |
|  | £'000 | £'000 |
|  | 108775 | 6679568 |

---

---

| | |
|:---|:---|
| | 31 December 2024 |
| | Fair value |
| Analysis: | £'000 |
| Current | 84080 |
| Non-current | 24695 |
| Total derivative financial liabilities | 108775 |

---

**Items that will or may be reclassified to the Consolidated Statement of Comprehensive Income:**

---

| | |
|:---|:---|
| | <br>31 December |
|  <br>Movement in year | 2024<br>£'000 |
| *Cash flow hedges* |  |
| (Losses) recognised on hedging instruments | (1318) |
| Tax relating to items that may be reclassified | 329 |
|  | (989) |

---

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**14. Derivative financial assets and financial liabilities (continued)**

*Interest rate swap contracts*

The Group has historically operated in a low interest rate environment. Since Q3 2022, when interest rates started to rise, the Group started to receive a large amount of interest on its own free cash balances as well as client cash balances. In line with the Group's treasury policy, we have entered into interest rate swap contracts to manage interest rate risk.

The interest rate swap contracts designated as hedging instruments relate to transactions entered into in 2022, 2023 and 2024 to fix the rate of interest receivable on cash balances held by the Group in respect of its own free cash balances as well as client cash balances. With the interest rate swap, the Group receives a fixed rate of interest and pays a floating interest rate based on The Bank of England SONIA.

The contracts have commencement dates between June 2023 and June 2025 with expiries between June 2025 and December 2025 for notional amounts of £650m and between January 2026 and December 2026 for notional amounts of £404m. Should the contracts no longer qualify for hedge accounting, the deferred gains/losses in other comprehensive income relating to the Group's own free cash balances will be reclassified within finance income and those relating to client cash balances will be reclassified within net treasury income – client funds. The hedge effectiveness is reassessed monthly and all hedges remained effective throughout 2024.

The following table analyses other comprehensive income in relation to hedge accounting:

---

| | |
|:---|:---|
| | 31 December 2024 |
| | £'000 |
| At 1 January | 2554 |
| Net fair value (losses) | (1318) |
| At 31 December | 1236 |

---

The following table shows the effects of hedge accounting on the Statement of Financial Position and the year-to-date performance for cash flow hedges taken out to hedge interest rate risk:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | Hedging instrument | Hedging instrument | Hedging instrument | Hedging instrument | Hedged item |
| | Carrying amount | Carrying amount | Carrying amount | Carrying amount | Change in fair |
| Hedged interest rate risk | Notional amount £'000 | Assets<br>£'000 | Liabilities<br>£'000 | Balance sheet presentation | value<br>£'000 |
| As at 31 Dec 2024 | 1054831 | 2099 | 863 | Derivatives | 1318 |

---

No changes in fair value have been taken to the income statement as there has been no hedge ineffectiveness to date.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**15. Financial instruments**

*Foreign currency forward contracts* 

The forward contracts designated as hedging instruments relate to hedges entered into in December 2022 and February 2023 to fix the exchange rate of interest receivable denominated in dollars and euros. The contracts had monthly expiries up to January 2024. Upon expiry of the contracts, the deferred gains/losses in comprehensive income relating to the hedges on the Group's free cash balances and client cash balances were reclassified to finance income and NTI – client funds respectively.

*Fair value measurement*

Forward and option contracts fall into level 2 of the fair value hierarchy as set out in note 2. Level 2 comprises those financial instruments which can be valued using inputs other than quoted prices that are observable for the asset or liability either directly (i.e., prices) or indirectly (i.e., derived from prices). The fair value of forward foreign exchange contracts is measured using observable forward exchange rates for contracts with a similar maturity at the reporting date. The fair value of option foreign exchange contracts is measured using an industry standard external model that best presents the unpublished interbank valuations. The fair value of interest rate contracts is measured using observable interest rates for contracts with a similar maturity at the reporting date.

There were no transfers between level 1 and 2 during the year. The fair value of all other financial assets and financial liabilities is approximate to their carrying value.

The principal financial instruments of the Group, from which financial instrument risk arises, are as follows:

---

| | |
|:---|:---|
| | 31 December 2024 |
| **a)Financial assets per statement of financial position** | £'000 |
| **Fair value assets** |  |
| Derivatives not designated as hedging instruments (note 14) | 159046 |
| Derivatives designated as hedging instruments (note 14) | 2099 |
| **Total fair value assets** | 161145 |
| **Amortised cost financial assets** |  |
| Trade receivables | 4041 |
| Other receivables excluding prepayments | 4926 |
| Cash and cash equivalents | 252468 |
| Fixed collateral | 10063 |
| **Total amortised cost assets** | 271498 |
| **Total financial assets** | 432643 |

---

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**15. Financial instruments (continued)**

---

| | |
|:---|:---|
| | <br>31 December 2024 |
| | <br>31 December 2024 |
| **b) Financial liabilities per statement of financial position** | £'000 |
| **Fair value liabilities** |  |
| Derivatives not designated as hedging instruments (note 14) | 107912 |
| Derivatives designated as hedging instruments (note 14) | 863 |
| **Total fair value liabilities** | 108775 |
| **Other payables measured at amortised cost** |  |
| Other payables and accruals | 44407 |
| **Total other payables** | 44407 |
| **Total financial liabilities** | 153182 |

---

**&nbsp;&nbsp;&nbsp;&nbsp;**

**c) Offsetting financial assets and financial liabilities**

Financial instruments at fair value through profit or loss represent immediate back-to-back derivative transactions with banking counterparties and are reported as financial assets and financial liabilities in the Consolidated Statement of Financial Position.

The transactions are subject to ISDA ("International Swaps and Derivatives Association") Master Agreements and similar master agreements which provide a legally enforceable right of offset in the normal course of business, the event of a default and the event of insolvency or bankruptcy. In accordance with the master agreements, contracts with banking counterparties are assessed daily on a net basis.

However, contracts with clients are assessed daily on a gross basis and therefore shown as separate financial assets and financial liabilities in the Consolidated Statement of Financial Position.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**15. Financial instruments (continued)**

The following financial assets and liabilities have been offset and are subject to enforceable netting agreements.

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  |  |  |  | **Gross amounts not offset** | **Gross amounts not offset** |  |
| <br>**2024** | **Gross fair value**<br>£'000 | **Variation margin offset**<br>£'000 | **Fair value Offset**<br>£'000 | **Net derivative financial asset/(liability) (Note 14)**<br>£'000 | <br>**Financial Instruments**<br>£'000 | **Fixed collateral**<br>£'000 | <br>**Net Amounts subject to offsetting arrangements** £'000 |
| Derivative financial assets | <br>226627  | <br>14333  | <br>&nbsp;&nbsp;&nbsp;&nbsp;(81914) | <br>**159046**  | <br>- | <br>10063  | <br>**169109** |
| Derivative financial liabilities | <br>(189826) | <br>-  | <br>81914  | <br>**(107912)** | <br>- | <br>-  | <br>**(107912)** |

---

**16. Financial risk management** 

**Objectives, policies and processes for managing and the methods used to measure risk** 

There have been no substantive changes in the Group's exposure to financial instrument risks, its objectives, policies and processes for managing those risks or the methods used to measure them from previous periods, unless otherwise stated in this note.

Financial assets principally comprise trade and other receivables, cash and cash equivalents, fixed collateral and derivative financial assets. Financial liabilities comprise trade and other payables, and derivative financial liabilities. The main risks arising from financial instruments are credit risk, liquidity risk, market risk, foreign currency risk, and interest rate risk, each of which are discussed in further detail below.

The Group monitors and mitigates financial risk on a consolidated basis. The Group has implemented a framework to ensure that risk management practices appropriate to a listed company are in place.

The Group operates under the Three Lines of Defence approach to risk management. This framework is overseen and enforced by the Risk Committee and Board.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.First Line is risk management: Primary responsibility for strategy, performance and risk management lies with the Executive Team and the Heads of each department.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Second Line is risk oversight: The Risk, Compliance, Finance and Legal Teams provide risk oversight.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Third Line is independent assurance: Independent assurance on the effectiveness of the risk management systems. Specialist external reviews provide an additional line of defence.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**16. Financial risk management (continued)**

**<br>Credit risk**

Credit risk is inherent in Alpha's business model. The Board accepts that credit losses are a function of our trading model, and the Group takes a risk-based approach to balance revenue opportunities against the risk of default. Credit risk is the risk that a client fails to deliver currency at maturity of a contract and/or fails to deposit margin when a margin call is made which could ultimately lead to a financial loss.

Where the Group provides credit to customers, this is subject to credit verification checks and where required an in-depth underwriting process by our Credit Team based on both quantitative and qualitative factors. Credit policies are aimed at reducing the impact of losses, credit terms will only be granted to customers who satisfy a creditworthiness assessment and demonstrate an appropriate payment history. The client terms and conditions and the credit facility confirmation letter highlight the client's margin terms and requirement to provide collateral. This provides further mitigation to the credit exposure and reduces the risk of potential disputes. The Group evaluated the concentration of risk as low with respect to derivative financial assets arising from contracts with counterparties. This is due to the fact that no single customer represents a significant proportion of the total value of customer contracts and the business has historically low levels of counterparty default.

Client credit exposures are monitored daily. Stress tests are carried out to assess and minimise client credit risk exposures under various market volatility scenarios.

*Counterparty risk*

The Group relies on third party institutions in order to trade with clients. To reduce counterparty credit risk, the Group only trades with private market counterparties with sufficiently robust balance sheets which we assess including through independently observable data, high credit ratings and strong capital resources. The Group monitors the creditworthiness of private market counterparties on an ongoing basis. As part of the Group's business continuity procedures settlement lines have been established with several private market counterparties in order to reduce the impact of business disruption as a result of counterparty risk.

The Group's maximum exposure to credit risk by class of financial asset is as follows:

---

| | |
|:---|:---|
| | 31 December 2024 |
| **Asset Category** | £'000 |
| Cash and cash equivalents | 252468 |
| Derivative financial assets | 161145 |
| Trade and other receivables | 8967 |
| **Total assets subject to credit risk** | **422580** |

---

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**16. Financial risk management (continued)**

**Credit risk (continued)**

Credit risk is mitigated as the majority of these financial assets are held with investment grade financial institutions with credit ratings assigned by reputable credit rating agencies such as Moody's, Standard & Poor's and Fitch Ratings.

The Group's financial assets breakdown by credit ratings is as follows:

---

| | |
|:---|:---|
| | 31 December 2024 |
|  **Cash and cash equivalents** | £'000 |
| A+ to A- | 246829 |
| BBB+ to BBB- | 5619 |
| Unrated | 20 |
| **Total cash and cash equivalents subject to credit risk** | **252468** |

---

---

| | |
|:---|:---|
| | 31 December 2024 |
|  **Derivative financial assets and trade and other receivables** | £'000 |
| A+ to A- | 4576 |
| BBB+ to BBB- | - |
| Unrated | 165536 |
| **Total derivative financial assets and trade and other receivables subject to credit risk** | **170112** |

---

**Liquidity risk &nbsp;&nbsp;&nbsp;&nbsp;**

Liquidity risk is the risk that the Group may encounter difficulty in meeting its financial obligations as they are due. Extensive controls are in place to ensure that liquidity risk is mitigated. The Group's liquidity requirements are reviewed daily, and the Group employs stress testing to model the sufficiency of its liquidity in stressed market scenarios. The ability of clients to pay margin and settle contracts is monitored with automated triggers and alerts configured into the Group's systems. The Group maintains cash reserves and continues to increase these reserves relative to its trading activity on an ongoing basis.

The Group attempts to ensure it maintains (as closely as possible) a balanced position in each currency, with regular stress testing of its net long/short position in a particular currency against sudden and unforeseen market movements.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**16. Financial risk management (continued)**

**Credit risk (continued)**

The Group has sufficient cash resources to pay its debts and contractual liabilities as they fall due. Consequently, management does not believe that the Group has a material exposure to liquidity risk. The following table sets out the contractual maturities (representing undiscounted contractual cash flows) of financial liabilities:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **At 31 December 2024** | **Total** | **<1 year** | **2-5 years** | **>5 years** |
|  | £'000 | £'000 | £'000 | £'000 |
| Other payables and accruals | 44407 | 44407 | - | - |
| Lease liabilities | 27606 | 3299 | 15857 | 8450 |
| Derivative financial liabilities\* | 9100315 | 6781918 | 2269802 | 48595 |
|  | 9172328 | 6829624 | 2285659 | 57045 |

---

\*The outflows disclosed in the above table represent the undiscounted contractual cash flows relating to derivative financial liabilities held for risk management purposes which are not typically closed out before contractual maturity. The disclosure shows gross cash flow amounts for derivatives held with banking counterparties.

**Market risk**

Market risk is also inherent in Alpha's business model, however this is minimised by operating a matched principle broker, whereby all derivatives sold to customers are matched on a back-to-back basis with an offsetting derivative from a banking counterparty. The Group is only exposed to the net position of its derivative assets and liabilities and this position is collateralised on a daily basis. The Group may from time to time buy treasury hedges from its banking counterparties, that are not matched with the client, to limit the tail risk of individual trades. The treasury hedges involve buying an option and therefore the Group has the right to trade rather than an obligation so there is no downside risk on these transactions.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**16. Financial risk management (continued)**

**Market risk (continued)**

*Interest rate risk* 

Interest rate risk is the risk that the value of a financial instrument or cash flows associated with the instrument will fluctuate due to changes in market interest rates. Interest rate risk arises from interest bearing financial assets and liabilities used by the Group. It is the Group's policy to settle derivative financial liabilities arising from contracts with customers (included within trade payables) and other payables within the credit terms allowed. Therefore, the Group generally does not incur interest on overdue balances.

Interest bearing assets comprise cash and cash equivalents which are considered short-term liquid assets. Furthermore, as detailed within note 2, the Group generates interest income (NTI – client funds) on our client balances and also on initial and variation margin balances (NTI – own funds). In 2024, we continued to manage the interest rate risk on interest receivable on our funds and client funds using interest rate swaps (note 14).

Interest rate sensitivity analysis has been performed by considering the impact of a 10% strengthening or weakening in the base rate that these balances' interest rates are linked to. The impact on the Group's profit after tax for the year would be an increase or decrease of £8.4m, respectively.

*Foreign currency risk*

Foreign currency risk refers to the risk that non-sterling revenue earned on a transaction may fluctuate due to changes in foreign currency rates. The Group is exposed to foreign currency risk on revenue, expenses and net assets that are denominated in a currency other than sterling. The principal currencies giving rise to this risk vary from period to period depending on the currency of transactions undertaken by the Group. Details of the foreign currency cash balances can be found in note 18.

The Group manages its exposure to currency movements in line with its Treasury Policy. Client money received in a foreign currency is deposited in a bank account of the same currency, netting off to provide a natural hedge. The Group reduces its exposure to foreign exchange by retranslating excess cash in foreign currencies into sterling on a regular basis. The Group hedges a proportion of its unrealised profits through foreign exchange contracts designated as fair value through profit or loss.

The Group's policy is to reduce the risk associated with the revenue denominated in foreign currencies by using forward fixed rate currency hedges. The settlement of these forward foreign exchange contracts is expected to occur within the following twelve months. Changes in the fair values of forward foreign exchange contracts are recognised directly in the Consolidated Statement of Comprehensive Income.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**16. Financial risk management (continued)**

**Market risk (continued)**

*Foreign currency risk – sensitivity analysis*

The Group's principal recurring foreign currency transactions are in Euros, US Dollar and Canadian Dollar. The table below shows the impact on the Group's operating profit and equity, of a 10% change in the exchange rate of the principal currencies, euro, US dollar and Canadian dollar.

---

| | | |
|:---|:---|:---|
| | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Impact on profit after tax** | **Impact on equity** |
| **Year ended 31 December** | 2024<br>£'000 | 2024<br>£'000 |
| **Euro:** |  |  |
| 10% weakening in the £/€ exchange rate | 8783 | 1521 |
| 10% strengthening in the £/€ exchange rate | (7186) | (1245) |
| **US dollar:** |  |  |
| 10% weakening in the £/$ exchange rate | 7106 | 2807 |
| 10% strengthening in the £/$ exchange rate | (5814) | (2297) |
| **Canadian dollar:** |  |  |
| 10% weakening in the £/$ exchange rate | 370 | 434 |
| 10% strengthening in the £/$ exchange rate | (302) | (355) |

---

The sensitivities in the table above do not include the impact of foreign exchange hedges in place to optimise cash management across the Group. By including the impact of hedges in place throughout 2024, the impact of a 10% weakening of the pound on profit after tax would have been £6,878k, £6,128k and £184k for Euro, US dollar and Canadian dollar respectively. Similarly, the impact of a 10% strengthening of the pound on profit after tax would have been -£5,628k, -£5,014k and -£150k for Euro, US dollar and Canadian dollar respectively.

---

| | |
|:---|:---|
| **Exchange rates for financial year** | **2024** |
| **Euro:** | |
| Average rate | 1.1814 |
| Closing rate | 1.2098 |
| **US dollar:** | |
| Average rate | 1.2780 |
| Closing rate | 1.2533 |
| **Canadian dollar:** | |
| Average rate | 1.7507 |
| Closing rate | 1.8019 |

---

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**16. Financial risk management (continued)**

**Market risk (continued)**

*Foreign currency risk – sensitivity analysis (continued)*

The impact of a change of 10% has been selected as this is considered reasonable given the current level of exchange rates and the volatility observed both on a historical basis and market expectations for future movement.

**Management of capital**

The Group's objectives when managing capital are to maximise shareholder value whilst safeguarding the Group's ability to continue as a going concern. The Group's policy is to maintain a capital base and funding structure that retains creditor and market confidence, provides flexibility for business development, ensures adherence to regulatory requirements, whilst optimising returns to shareholders.

The Group monitors its total equity as shown in the Consolidated Statement of Financial Position. In order to maintain or adjust the capital structure, the Company may issue new shares, adjust the dividends paid to shareholders or buy back shares.

**17. Trade and other receivables**

---

| | |
|:---|:---|
| | 31 December 2024 |
| | £'000 |
| Trade receivables<br>Other receivables | 4041 <br> 4926 |
| Prepayments | 3748 |
| **Total trade and other receivables** | **12715** |

---

Trade receivables consist of invoices owed from clients. Other receivables consist primarily of accrued interest, amounts held on account with the Group's broker available for share buybacks and rental deposits. Receivables are considered current assets and reported at their fair value.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**18. Cash** 

Cash and cash equivalents comprise cash balances and deposits held at call with banks for which the Group has immediate access.

Fixed collateral comprises cash held as collateral with banking counterparties for which the Group does not have immediate access.

Cash balances included within derivative financial assets (see notes 14 and 15) relate to the variation margin called by banking counterparties for which the Group does not have immediate access.

---

| | |
|:---|:---|
| | 31 December 2024 |
| | £'000 |
| Cash & cash equivalents | 252468 |
| Variation margin (note 15) | (14333) |
| Fixed collateral | 10063 |
| **Total cash** | **248198** |

---

Cash at bank is made up of the following currency balances:

---

| | |
|:---|:---|
| | 31 December 2024 |
| | £'000 |
| British pound | 164447 |
| Euro  | 44022 |
| US Dollar | 8335 |
| Canadian Dollar | 3709 |
| Australian Dollar | 12981 |
| Norwegian Krone | 5607 |
| Polish Zloty | 4358 |
| New Zealand Dollar | 3896 |
| Other currencies | 843 |
|  | 248198 |

---

The Directors consider that the carrying amount of cash and cash equivalents approximates to their fair value.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**19. Capital and reserves** 

***Share capital and Treasury shares***

---

| | | | |
|:---|:---|:---|:---|
| <br>***Authorised, issued and fully paid*** | Ordinary shares<br>No. | Share capital<br>£'000 | Treasury shares<br>£'000 |
| **At 1 January 2024** | **43321813** | **87** | **-** |
| Acquisition of treasury shares\* | (524772) | - | (10721) |
| Treasury shares issued on vesting of share option schemes\*\* | 234627 | - | 4024 |
| **At 31 December 2024** | **43031668** | **87** | **(6697)** |

---

In January 2024, Alpha initiated a £20m share buyback programme. In June 2024, a second buyback programme of £20m was implemented which continued to run into 2025. At 31 December 2024, £10m of this second programme had been executed.

\*During the year, in addition to the £10.7m of treasury share purchases shown above, £19.3m of purchases of shares by the Company were made otherwise than in accordance with UK Companies Act 2006. At 31 December 2024, this amount has been classified within retained earnings, rather than the Treasury share reserve.

\*\*In March 2024, the Company issued 234,627 shares from treasury totalling £4,024,051 following the vesting of shares under the Institutional, Canada, Alpha Pay and Netherlands share schemes.

***Share premium account***

There were no movements in the share premium account in the year ended 31December 2024.

***Retained earnings***

Represents accumulated profits attributable to equity owners of the parent less accumulated dividends.

***Other reserves***

Other reserves are made up of the following balances:

---

| | |
|:---|:---|
| | 31 December 2024 |
| | £'000s |
| Capital redemption reserve | 4 |
| Merger reserve | 667 |
| Redemption reserve | (1884) |
| Translation reserve | (1873) |
| Total | (3086) |

---

**19. Capital and reserves (continued)**

***Capital redemption reserve***

The capital redemption reserve of £3,701 arose following the buy-back of shares in prior years.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

***Merger reserve***

The merger reserve of £666,529 was created in October 2016 as a result of a share for share exchange with non-controlling interests. The merger relief reserve represents the difference between the fair value and nominal value of shares issued on the acquisition of non-controlling interests, where the Company has taken advantage of merger relief.

***Redemption reserve***

The redemption reserve of £(1,884,165) comprises the fair value of the consideration payable to the non-controlling interest of Financial Transaction Services B.V. (Cobase) on the date that the agreement was entered into. The reserve is expected to be utilised over a four-year period between 31 December 2025 and 31 December 2028, with 25% of the non-controlling interest acquired each period over the four years. More details on the acquisition can be found in note 23.

***Translation reserve***

The translation reserve of £(1,873,148) represents the foreign exchange differences arising from the translation of the net investment in foreign entities.

Throughout 2024 and in 2025 prior to the Corpay acquisition, the Board maintained a progressive dividend policy, coupled with the execution of value-capped share buybacks, retaining and deploying our remaining cash to grow the business.

**20. Other payables and Deferred income**

---

| | |
|:---|:---|
| | 31 December 2024 |
| **Current:** | £'000 |
| Other payables | 35735 <br> 1340 <br> 3512 |
| Other taxation and social security | 1340 |
| Accruals | 8672 |
|  | 45747 |
| **Non-current:** |  |
| Provisions | 885 |
|  | 885 |
| **Total other payables** | **46632** |

---

Other payables consists of margin received from clients. The carrying value of other payables classified as financial liabilities measured at amortised cost, approximates fair value.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**20. Other payables and Deferred income (continued)**

**Deferred income**

The changes in the Group's deferred income during the year are as follows:

---

| | |
|:---|:---|
| | 31 December 2024 |
| | £'000 |
| At 1 January | 7072 |
| Recognised as revenue during the year | (17184) |
| Deferred during the year | 18171 |
| At 31 December | 8059 |

---

**21. Related party transactions and balances**

Parties are considered to be related if one party has the ability to control the other party or exercise significant influence over the other party in making financial or operational decisions, or one other party controls both.

**Subsidiaries**

The Parent company of the Group is Alpha Group International Limited. Note 13 provides information about the subsidiaries and the holding company. Details of the ultimate controlling party can be found in note 24.

Transactions between the Group and its subsidiaries have been eliminated on consolidation and are not disclosed in this note.

**Key management personnel** 

The Group considers its key management personnel to be those personnel who have authority and responsibility for planning, directing and controlling the activities of the Group, including the Non-Executive Directors.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**21. Related party transactions and balances (continued)**

The total remuneration of the Directors for the year ended 31 December 2024 is shown in the table below:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Director** |  | **Salary/fees £'000** | **Benefits**<sup>1</sup> **£'000** | **Pension**<sup>2</sup> **£'000** | **Fixed pay Sub-total £'000** | **Annual bonus**<sup>3</sup> **<br>£'000** | **Other** | **Variable pay Sub-total £'000** | **Total <br>£'000** |
| **Executive directors** |  |  |  |  |  |  |  |  |  |
| Morgan Tillbrook | 2024 | 500 | 5 | 4 | 509 | 620 | – | 620 | **1129** |
| Tim Powell | 2024 | 325 | 1 | 4 | 330 | 515 | – | 515 | **845** |
| Tim Butters | 2024 | 300 | 1 | 4 | 305 | 50 | – | 50 | **355** |
| **Non-executive directors** |  |  |  |  |  |  |  |  |  |
| Clive Kahn<sup>5</sup> | 2024 | 153 | – | – | 153 | – |  | – | **153** |
| Vijay Thakrar | 2024 | 53 | – | – | 53 | – |  | – | **53** |
| Jayne-Anne Gadhia<sup>4</sup> | 2024 | 79 | – | 2 | 81 | – |  | – | **81** |
| Lisa Gordon<sup>6</sup> | 2024 | 18 | - | – | 18 | – |  | – | **18** |

---

Notes:

1&nbsp;&nbsp;&nbsp;&nbsp;Benefits paid to Clive Kahn, Tim Powell and Tim Butters comprised the provision of private medical insurance.

2&nbsp;&nbsp;&nbsp;&nbsp;Executive Directors received a contribution to a defined contribution pension scheme.

3&nbsp;&nbsp;&nbsp;&nbsp;2024 bonuses are payable in cash.

4&nbsp;&nbsp;&nbsp;&nbsp;Jayne-Anne Gadhia joined the Board as Chair Designate on 1 May 2024 and stepped up to Chair on 1 November 2024.

5 Clive Kahn stepped down from being the independent Chair of the Board on the 1 November 2024 before taking up the role of CEO on 1 January 2025. His salary reflects 10 months at £53,000 and two months at £650,000.

6 &nbsp;&nbsp;&nbsp;&nbsp;Lisa Gordon stepped down from the Board on 1 May 2024.

<u>Transactions with key management personnel</u> 

During the year, Alpha FX Limited did not trade gross foreign currency contracts with any key management personnel.

**Other related parties**

During the year, Alpha FX Limited traded gross foreign currency contracts with individuals classified as related parties as follows; Martin Tillbrook £42,095, being the father of M J Tillbrook, on an arm's length basis. Revenue of £204 was recognised on the contract.

**Other entities**

During the year, the Group purchased goods and services from entities classified as related parties as follows:

-Services totalling £223,311 on an arms-length basis from Assured Cyber Limited, a cyber insurance broker in which M J Tillbrook owns a 28.8% beneficial ownership.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**21. Related party transactions and balances (continued)**

During the year, the Group traded gross foreign currency contracts with entities classified as related parties as follows:

-Gross foreign currency contracts of £700,000 on an arms-length basis, with Zip Cap Limited, a financial services company in which M J Tillbrook owns 100% of the share capital. Revenue of £5 was recognised on the contract.

**22. Share-based payments** 

Employees (including senior executives) of the Group receive remuneration in the form of share-based payments, whereby employees render services as consideration for equity instruments (equity-settled transactions).

The Group has three types of share option schemes for certain employees of the Group, all of which are equity-settled share-based payments.

The current share option schemes in place are grouped together as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Growth Share Schemes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Underlying Profit After Tax (UPAT) Share Schemes; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Group Incentive Plans.

External tax valuations for share schemes are obtained from an independent third party prior to issue. Indemnities are also obtained from all employees for any future tax liabilities that may arise.

Should any additional payroll tax liabilities arise, in the first instance, they would be paid by the subsidiary company, and the tax indemnities would ensure recovery of any additional tax liabilities from the growth shareholders.

The Group recognised a total charge related to all the above equity-settled share-based payment transactions in the year ended 31 December 2024 of £5,324,678.

***22.1 Growth Share Schemes***

The Group operates several growth share schemes where shares in subsidiary entities are awarded to employees and are converted into shares in the Company at a future date based on pre-determined vesting criteria.

Upon conversion, the number of ordinary shares in the Group a growth share scheme shareholder will receive is such number of ordinary shares whose value is equivalent to the Group's average closing share price over 60 business days prior to the announcement of the Group's results for the year. Conversion is only permitted to the extent that the shares have vested.

In April 2024, the Group issued shares under the J and L Share Growth Schemes. The shares contain a put option, such that, when and to the extent vested, they can be converted into ordinary shares in the Parent Company.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**22. Share-based payments (continued)** 

***22.1 Growth Share Schemes (continued)***

The Group recognised a share-based payment charge relating to the Growth Share Schemes of £3,182,410 in the year ended 31 December 2024.

Details of the general terms and conditions of the growth share schemes including vesting requirements are noted below:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | B Growth<br>Share Scheme<sup>1</sup> | E Growth Share scheme<sup>2</sup> | F Growth Share Scheme<sup>2</sup> | &nbsp;&nbsp;&nbsp;G Growth Share <br>Scheme<sup>2 3</sup> | &nbsp;&nbsp;&nbsp;H Growth Share <br>Scheme<sup>2 3</sup> | &nbsp;&nbsp;&nbsp;J Growth Share <br>Scheme<sup>2</sup> | &nbsp;&nbsp;&nbsp;L Growth<br> Share Scheme<sup>2 3</sup> |
| Launch year | 2017 | 2020 | 2022 | 2022 | 2022 | 2024 | 2024 |
| *Vesting conditions* |  |  |  |  |  |  |  |
| No. of tranches\* | 5 | 4 | 4 | 5 | 5 | 5 | 5 |
| Vesting start date | Dec 31, 2017 | Dec 31, 2021 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2022 | Dec 31, 2024 | Dec 31, 2024 |
| Vesting end date\*\* | Dec 31, 2021 | Dec 31, 2024 | Dec 31, 2026 | Dec 31, 2026 | Dec 31, 2026 | Dec 31, 2028 | Dec 31, 2028 |
| *Revenue growth target* |  |  |  |  |  |  |  |
| Year 1 | 30% | 25% | 20% | 5.5% | 5.5%\|18.6% | 20% | 15% |
| Year 2 | 30% | 20% | 20% | 15% | 15%\|20% | 20% | 15% |
| Year 3 | 30% | 20% | 20% | 15% | 15%\|20% | 20% | 15% |
| Year 4 | 20% | 20% | 20% | 15% | 15%\|20% | 15% | 10% |
| Year 5 | 20% | n/a | n/a | 15% | 15%\|20% | 15% | 10% |
| *Market capitalisation\*\*\** |  |  |  |  |  |  |  |
| Minimum | £25m | £300m | £740m | £740m | £740m | £761m | £761m |
| Maximum | - | £650m | £1,867m | £1,867m | £1,867m | £1,694m | £1,694m |

---

\* The shares in the growth schemes vest in equal tranches, occurring annually, starting on the vesting start date until the end date specified above.

\*\*The vesting end date is defined as the end period of the non-market performance conditions being met. The market condition that determines the number of shares to be issued is not confirmed until the full year results are announced the following year in March.

\*\*\*The rate of conversion of the shares for the year ended 31 December 2024 is a pro rata share of the market capitalisation gain of Alpha above a minimum hurdle price over a 60-business day period from 20<sup>th</sup> December 2024 to 18<sup>th</sup> March 2025. The gain is then capped through placing a ceiling on the maximum market capitalisation. The result in doing so is that the shareholders will be entitled to a pro rata share of the gain in market capitalisation of Alpha between the minimum and maximum market capitalisation.

<sup>1</sup> In March 2022, following the revenue growth target for the year being met in respect of the year ended 31 December 2021, B Growth Shares were exercised when the share price of the Company was 1909p. 88,015 shares will be issued as consideration to an ex-employee in March 2025 as part of a settlement agreement. This represents the final vesting of the B Growth Share Scheme.

<sup>2</sup> In respect of the year ending 31 December 2023, revenue growth targets for the Growth Share Schemes were not met, resulting in lapsed shares. Accordingly, no shares in the Parent Company were issued as consideration in March 2024. With respect to the year ending 31 December 2024, the revenue targets for the E, F, J and L Shares were met.

<sup>3</sup> On 26 April 2024, the Group announced that the L Share Growth Scheme would replace the existing G Growth Share Scheme and H Share Growth Scheme launched in 2022 to ensure that employees within the Corporate division were part of a unified scheme. Accordingly, the existing G Growth Share Scheme and H Share Growth Scheme were cancelled by way of a capital reduction on 12 March 2025. The revenue growth targets for the L Share Growth Scheme for each financial year are based on the London and Spain-based operations of the Corporation division, whereas revenue growth targets for schemes B, E, F and J are based on Group revenue.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**22. Share-based payments (continued)** 

***22.1 Growth Share Schemes (continued)***

Details of the outstanding share options in respect of the above schemes are as follows:

---

| | | |
|:---|:---|:---|
| | &nbsp;&nbsp;&nbsp;Year ended 31 December 2024 | &nbsp;&nbsp;&nbsp;Year ended 31 December 2024 |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>Number | Weighted Average Exercise Price<br>£ |
| Outstanding at beginning of year | 1524 | 1178 |
| Granted in the year | 1370 | 1327 |
| Exercised in the year | - | - |
| Forfeited in the year | (586) | 1365 |
| Expired in the year | (583) | 1095 |
| Outstanding at end of year | 1725 | 1261 |
| Number of options exercisable at end of year | 481 | 1195 |

---

---

| | |
|:---|:---|
| | Year ended 31 December 2024 |
| Weighted average fair value of options granted (£) | 9160 |
| Weighted average share price at date of exercise (£) | - |
| Weighted average remaining contractual life (years) | 3.6 |

---

The fair values of the Growth Share Schemes were calculated using a Monte Carlo simulation model due to the existence of market-based performance conditions (market capitalisation). The model considers historic and expected dividends, and the share price volatility of the Group relative to that of its competitors, to predict the share performance. When determining the grant date fair value of awards, service and non-market performance conditions are not considered. However, the likelihood of the conditions being met is assessed as part of the Group's best estimate of the number of equity instruments that will ultimately vest. Market performance conditions are reflected within the grant date fair value.

The inputs used for fair valuing the awards at the date of grant were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | B Growth<br>Share Scheme | E Growth<br>Share Scheme | F, G & H Growth Share Schemes | J & L Growth Share Schemes |
| Date of grant | 25 January 2017 | 11 May 2020 | 22 June 2022 | 26 April 2024 |
| Expected volatility % | 25.0% | 45%-55% | 40% | 40% |
| Risk free interest rate % | 0.09% | 0.10% | 2.30% | 4.60% |
| Option life (years) | 3 | 5 | 5 | 6 |
| Starting equity value (£m) | £33.6m | £300.0m | £740.0m | £761.0m |

---

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**22. Share-based payments (continued)** 

***22.2 UPAT Share Schemes***

These share schemes award participants with the option to convert a percentage of their holding into Group shares based upon strict performance criteria. The value of which is determined by applying an 8x multiple to the underlying profit after tax (UPAT) achieved by the relevant division. Upon vesting, the subsidiary shares are exchanged for shares in the Parent Company, with the number of shares calculated based on an agreed valuation conversion ratio. This share scheme ensures that awards are directly tied to the financial success of the subsidiary divisions.

Select employees of these schemes have shares in the relevant subsidiaries which also have dividend rights. However, as the shares are not paid for until exercise, upon which they are immediately converted into shares of Alpha Group International Limited, the shares are accounted for under IFRS 2 Share-Based Payment, rather than a non-controlling interest in a subsidiary.

In April 2024, the Group announced a new share scheme to incentivise key personnel of the Italian Branch of Alpha FX Europe Limited. Following the launch of the Fund Finance division in 2023, the Group announced a new share scheme to incentivise key personnel within the Fund Finance division. The shares will vest in equal tranches over the determined vesting period for each of the financial years.

Following leadership changes in late 2023, the Alpha Canada Employee Share Scheme in Alpha Foreign Exchange (Canada) Limited was cancelled on 30 December 2024 and replaced with a cash bonus model.

The Group recognised a share-based payment charge relating to the UPAT schemes of £314,353 in the year ended 31 December 2024.

Share schemes are in place for the following subsidiaries:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Alpha FX Institutional Limited ('Institutional')

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Alpha FX Limited ('Alpha Pay', 'Bristol' and 'Fund Finance')

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Alpha FX Netherlands Limited ('Netherlands')

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Alpha FX Europe Limited ('Italy')

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**22. Share-based payments (continued)** 

***22.2 UPAT Share Schemes (continued)***

Details of the general vesting conditions of the schemes are noted below:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | Launch year | No. of tranches | Vesting start date | Vesting end date |
| <br>Institutional | Grant 1 | 2018 | 4 | 31 Dec 2021 | 31 Dec 2024 |
| <br>Institutional | Grant 2 | 2019 | 4 | 31 Dec 2022 | 31 Dec 2025 |
| <br>Institutional | Grant 3 | 2022 | 4 | 31 Dec 2024 | 31 Dec 2027 |
| <br>Alpha Pay | Grant 1 | 2019 | 4 | 31 Dec 2022 | 31 Dec 2025 |
| <br>Alpha Pay | Grant 2 | 2021 | 4 | 31 Dec 2023 | 31 Dec 2026 |
| <br>Alpha Pay | Grant 3 | 2021 | 4 | 31 Dec 2024 | 31 Dec 2027 |
| Netherlands | Grant 1 | 2021 | 4 | 31 Dec 2023 | 31 Dec 2026 |
| Bristol | Grant 1 | 2023 | 4 | 31 Dec 2024 | 31 Dec 2027 |
| Fund Finance | Grant 1 | 2024 | 4 | 31 Dec 2025 | 31 Dec 2028 |
| Italy | Grant 1 | 2024 | 4 | 31 Dec 2025 | 31 Dec 2028 |

---

The table below summarises the outstanding options for the UPAT schemes in aggregate, across the four subsidiaries listed above.

---

| | | |
|:---|:---|:---|
| Year ended 31 December 2024 |  | Weighted Average Exercise Price |
|  | Number | £ |
| Outstanding at beginning of year | 16315 | 251 |
| Granted in the year | 395 | 3222 |
| Exercised in the year | (3062) | 99 |
| Forfeited in the year | (6671) | 26 |
| Outstanding at end of year | 6977 | 702 |
| Number of options exercisable at end of year | 2474 | 423 |

---

---

| | |
|:---|:---|
| | Year ended 31 December 2024 |
| Weighted average fair value of options granted (£) | 4813 |
| Weighted average share price at date of exercise (£) | 99 |
| Weighted average remaining contractual life (years) | 2.6 |

---

The UPAT share schemes do not have any market-based performance criteria. As the value of the shares is a function of the put option proceeds and dividend distributions during the holding period, they have been valued using the discounted cashflow method. A simulation of the equity value at the end of the vesting period is performed using a Monte Carlo simulation model.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**22. Share-based payments (continued)** 

***22.2 UPAT Share Schemes (continued)***

The inputs used for fair valuing the awards at the date of grant were as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | Institutional | Alpha Pay | Netherlands | Bristol | Fund Finance | Italy |
| Issuing entity | Alpha FX Institutional Limited | Alpha FX Limited | Alpha FX Netherlands Limited | Alpha FX Limited | Alpha FX Limited | Alpha FX Europe Limited |
| Date of grant | 23 July 2018<br>20 November 2019<br>16 March 2022 | 20 November 2019<br>23 December 2021 | 28 May 2021 | 5 January 2023 | 26 April 2024 | 26 April 2024 |
| Exercise price (£) | 158-3550 | 8.4-243 | 930 | 1070-1240 | 4175-4886 | 1327-1553 |
| Expected volatility % | 35% | 35%-38% | 39% | 40% | 50% | 50% |
| Risk free interest rate % | - | 0.50%-0.73% | 0.36% | 3.50% | 4.19% | 4.19% |
| Option life (years) | 6-6.5 | 5-6 | 5.5 | 5 | 5 | 5 |

---

Expected volatility is based on historic volatility in the share price over the vesting period prior to the award.

***22.3 Group Incentive Plans***

In April 2024, the Group announced a new Group Incentive Plan that was put in place as part of the move to the Main Market. The options are being granted over shares in the Parent Company and the number of shares awarded are linked to the performance of key personnel within the German Branch of Alpha FX Europe Limited, Alpha FX Netherlands Limited and Cobase.

The value of the options upon conversion into shares for the schemes are based on multiples of either the operation's underlying profit after tax or the entity's revenue.

Awards under the Group Incentive Plans will vest in equal tranches, occurring annually.

The Group recognised a share-based payment charge relating to the Group Incentive Plans of £1,827,915 in the year ended 31 December 2024.

Details of the general terms and conditions of the Group Incentive Plans are noted below:

---

| | | | |
|:---|:---|:---|:---|
|  | &nbsp;&nbsp;Germany Scheme | &nbsp;&nbsp;Netherlands<br>Scheme | &nbsp;&nbsp;Cobase Scheme |
| Launch year | 2024 | 2024 | 2024 |
| *Vesting conditions* |  |  |  |
| No. of tranches | 4 | 4 | 5 |
| Vesting start date | Dec 31, 2026 | Dec 31, 2025 | Dec 31, 2024 |
| Vesting end date | Dec 31, 2029 | Dec 31, 2028 | Dec 31, 2028 |

---

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**22. Share-based payments (continued)** 

***22.3 Group Incentive Plans (continued)***

Details of the outstanding options in respect of the above schemes are as follows:

---

| | | |
|:---|:---|:---|
| | &nbsp;&nbsp;Year ended 31 December 2024 | &nbsp;&nbsp;Year ended 31 December 2024 |
| | &nbsp;&nbsp;<br>Number | &nbsp;&nbsp;Weighted<br> Average Exercise Price<br>£ |
| Outstanding at beginning of year | - | - |
| Granted in the year | 9091 | 0.1 |
| Outstanding at end of year | 9091 | 0.1 |
| Number of options exercisable at end of year | 1743 | - |

---

---

| | |
|:---|:---|
| | &nbsp;&nbsp;<br>Year ended 31 December 2024 |
| Weighted average fair value of options granted (£) | 1564 |
| Weighted average share price at date of exercise (£) | - |
| Weighted average remaining contractual life (years) | 4.3 |

---

The inputs used for fair valuing the awards at the date of grant using a Monte Carlo simulation model were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | &nbsp;&nbsp;31 December 2024 | &nbsp;&nbsp;31 December 2024 | &nbsp;&nbsp;31 December 2024 | &nbsp;&nbsp;31 December 2024 |
| | | &nbsp;&nbsp;Germany scheme<br>No. | &nbsp;&nbsp;Netherlands scheme<br>No. | &nbsp;&nbsp;Cobase<br>scheme<br>No. |
| Date of grant | 26 April 2024 | 26 April 2024 | 26 April 2024 | 12 December 2024 |
| Exercise price per share received (£) | 2 | 2 | 2 | nil |
| Expected volatility % | 40%-50% | 40%-50% | 35-40% | 35-40% |
| Risk free interest rate % | 4.14 | 4.14% | 4.14% | 4-4.38% |
| Option life (years) | 5.3 | 5.3 | 4.3 | 4.3 |

---

The exercise price of the Germany and Netherlands options awarded under the Group Incentive Plan is £2 per share received for each option exercised, whilst the Cobase options have been issued at nil cost.

Volatility has been estimated by taking the historical volatility of Alpha's price and guideline companies over the vesting period.

**23. Redemption Liability**

On 1 December 2023, Alpha Group International Limited acquired 86.36% of Financial Transaction Services B.V. (trading as "Cobase"), a leading multibank connectivity platform.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

Cobase is an innovative, cloud-based provider of bank connectivity technology that enables corporates to manage their banking relationships, accounts, and transaction activity via one single interface. In doing so, the company unlocks significant operational and financial efficiencies, especially for international businesses with multiple banking counterparties across the world. Alpha believes there are opportunities to amplify one another's growth by leveraging and sharing each other's unique capabilities and experience.

The purchase price allocation (shown in the table below) has now been finalised and is unchanged from that disclosed in the prior year on a provisional basis in accordance with IFRS 3 Business Combinations. The initial consideration for the acquisition was €9.6m (£8.3m) in cash, with the remaining stake to be acquired via a performance-based earn-out between 2025 and 2028.

The fair value of the net assets acquired on 1 December 2023 is set out below:

---

| | | | |
|:---|:---|:---|:---|
| | **Book value** | **Fair value adjustments** | **Fair value** |
| | £'000 | £'000 | £'000 |
| Intangible assets | 3292 | 980 | 4272 |
| Property, plant and equipment | 9 | - | 9 |
| Right-of-use-asset | 182 | - | 182 |
| Trade and other receivables | 1322 | - | 1322 |
| Cash and cash equivalents | 53 | - | 53 |
| Trade and other payables | (1354) | - | (1354) |
| Lease liabilities | (182) | - | (182) |
| Dilapidation provision | (63) | - | (63) |
| Deferred tax liabilities | 143 | (245) | (102) |
| **Total identifiable net assets** | 3402 | 735 | 4137 |
| **Non-controlling interest** |  |  | (564) |
| Goodwill on the business combination |  |  | 4707 |
| **Discharged by:** |  |  |  |
| Cash consideration |  |  | 8280 |

---

Goodwill of £4,707k reflects certain intangible assets that cannot be individually separated and reliably measured due to their nature. These items include the value of expected synergies arising from the business combination and the experience and skill of the acquired workforce. The fair value of the acquired software, brand name and customer relationships identified are included in intangible assets.

Transaction costs relating to professional fees and integration costs associated with the business combination in the year ended 31 December 2024 were £486,633.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**23. Redemption Liability (continued)** 

Included in the Consolidated Statement of Financial Position at 31 December 2023 was redemption liability of £1.9m. This represents the fair value of the consideration payable to the non-controlling interest of the subsidiary Cobase on the date that the agreement was entered into, based on the acquisition date fair value determination. The opposite entry was recognised on acquisition within the redemption reserve in equity. 25% of the non-controlling interest is to be acquired each period over a four-year period between 31 December 2025 and 31 December 2028.

During the year, the Group acquired a further 0.51% interest in Cobase, leaving a residual 13.13% outstanding. The consideration payable for each of the four tranches to be acquired will be determined based on actual revenue and/or profit realisation by the Cobase business in the relevant financial year ending 31 December. The carrying value of the liability has accordingly been re-assessed at the end of 2024 to be £1.8m, based on the latest budgeted and forecast revenue and profit estimates for the next four years, discounted at a rate commensurate with the risk around realisation and time value of money. The resulting gain of £0.1m has been reflected through operating expenses.

As set out in Note 25 below, the remaining interest in Cobase was acquired for consideration of £3.5m in October 2025.

**24. Ultimate controlling party**

As at the date of this report, the ultimate controlling party of the Company is Corpay Inc., a company incorporated in Delaware, USA.

**25. Events after the reporting period**

**Founder incentive grants**

On 11 February 2025, Morgan Tillbrook, founder and former CEO of Alpha pledged 1,103,555 ordinary shares (delivered in the form of nil cost options) of 0.2p each from his personal holding with a total value of circa £28m based on the closing share price of £25.40 on 11 February 2025. These shares were awarded to Board directors and members of the senior leadership team to both thank them for historic performance and incentivise them for future performance. These shares meet the definition of Share based payments under IFRS 2. From the period post award until the completion of the Corpay acquisition (see further below), these awards were treated as such.

**Issue of share capital and transfer of Treasury shares to settle December 2024 share award vestings**

In March 2025, the Group issued 250,000 new ordinary shares following finalisation of the Group's 2024 Annual Report, the Group transferred some 610,676 shares to satisfy the Company's obligations under the various equity schemes with a performance period ended 31 December 2024. This obligation was settled by the transfer of 340,676 shares held in treasury by the Company, together with the issue of 250,000 new ordinary shares of 0.2p nominal value.

**25. Events after the reporting period (continued)** 

**Issue of share capital and transfer of Treasury shares to settle December 2024 share award vestings**

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

In March 2025, the Group issued 250,000 new ordinary shares following finalisation of the Group's 2024 Annual Report, the Group transferred some 610,676 shares to satisfy the Company's obligations under the various equity schemes with a performance period ended 31 December 2024. This obligation was settled by the transfer of 340,676 shares held in treasury by the Company, together with the issue of 250,000 new ordinary shares of 0.2p nominal value.

**Distributable reserves**

As set out in note 19, £19.3m of purchases of shares by the Company during the year were made otherwise than in accordance with the UK Companies Act 2006. In addition, during the period from 1 January 2025 to 12 March 2025, the Group similarly repurchased £3.5m of shares otherwise than in accordance with the Act.

Details of the transactions which are affected by this issue (the "Relevant Purchases") are set out in the below table.

---

| | | | |
|:---|:---|:---|:---|
| <br>Date range | Aggregate number of shares | Aggregate price paid (£) | Average price per share (£) |
| Total for the year ended 31 December 2024 | 919945 | 19283343 | 20.96 |
| 1 Jan 2025- 12 March 2025 (inclusive) | 143611 | 3447131 | 24.00 |
| Total for the period to 12 March 2025 | 1063556 | 22730474 | 21.37 |

---

In addition, and as set out in Note 9, the Company has discovered that the interim dividend for the year ended 31 December 2024 (£1.8m) and the interim dividends paid on 13 October 2017 and the FY21 interim dividend paid on 8 October 2021 (together £0.7m) were made otherwise than in accordance with the UK Companies Act 2006.

After the year end, the necessary steps were taken in order to rectify the position of the Company and its counterparties, as if the transactions had originally been undertaken on a basis consistent with the UK Companies Act 2006.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**25. Events after the reporting period (continued)** 

**Declaration and payment of a final dividend for the year ended 2024**

On 18 March 2025, the Directors proposed a final dividend having satisfied themselves as to the adequacy of distributable reserves of the Company as at 28 February 2025 based on the Interim Accounts for the period to 28 February 2025 referred to above.

The Directors proposed that a final dividend in respect of the year ended 31 December 2024 of 14.0p per share amounting to circa £5,870k, which approved at the AGM and was paid on 23 May 2025 to all shareholders on the register of members on 25 April 2025.

**Awards under Group LTIP Scheme**

On 25 August 2025 and in accordance with the Group Remuneration Policy which was approved at the AGM in May 2025, Tim Powell (CFO) and Tim Butters (CRO) were granted awards over 23,657 and 11,296 shares, respectively under the Group Long-Term Incentive Plan (LTIP).

**Acquisition by Corpay Inc.** 

On 23 July 2025, it was announced that the Board of Directors of Alpha Group International Limited and Corpay Inc. had reached an agreement on the terms of a recommended cash acquisition of the entire issued and to be issued ordinary share capital of Alpha by Corpay, by means of a Court approved Scheme of Arrangement.

On 2 September 2025, shareholder approval for the both the acquisition and the proposed Scheme of Arrangement were obtained following a Court meeting and a general meeting.

On 31 October 2025, and following receipt of the necessary regulatory approvals, 100% of the outstanding share capital of Alpha Group International plc (i.e. all shares other than those held in treasury) was acquired by US-based Corpay Inc. for headline consideration of circa £1.8bn ($2.3bn).

As part of the acquisition, all relevant individuals holding options or rights to share awards yet to vest under the Group's various equity incentive schemes (including the Executive LTIP Scheme and the Founder Incentive Scheme) reached agreement with the Company to surrender all future rights under these schemes in return for fixed cash and, in certain cases, equity awards which immediately vested. All equity vestings were subsequently acquired by Corpay in exchange for a fixed sum of cash paid to the individuals.

------

**Notes to the Consolidated Financial Statements**

For the year ended 31 December 2024

**25. Events after the reporting period (continued)**

**Acquisition by Corpay Inc. (continued)**

In aggregate the total amount of cash owing to the relevant individuals was £35m, considered part of the acquisition consideration. The majority of these payments owing to the relevant individuals was made in November 2025, although a proportion of proceeds owing to certain individuals have been deferred for a year and remain subject to certain conditions, principally continuing service within the Corpay Group.

Also as part of the acquisition, Alpha Group International Limited acquired the remaining non-controlling interest in Cobase for circa £2m.

On 31 October 2025, the Chairman and all other non-Executive Directors stood down from the Board. On 5 November 2025, Alpha Group International Plc which was formerly registered as a public company, was re-registered as a private company limited by shares under the name of Alpha Group International Ltd.

## Exhibit 99.2

**Alpha Group International Limited and its subsidiaries**

Unaudited Condensed Consolidated Financial Statements

June 30, 2025

------

**Interim Condensed Consolidated Statement of Comprehensive Income**

---

| | | | |
|:---|:---|:---|:---|
| | | **Six months ended**<br>**30 Jun 2025** | **Six months ended**<br>**30 Jun 2024** |
|  | *Note* | **£'000** | **£'000** |
|  | *Note* |  |  |
| **Revenue** |  | **86209** | **64325** |
| Net treasury income – client funds | *4* | 38581 | 41781 |
| Net treasury income – own funds | *4* | 569 | 664 |
| **Total income** |  | **125359** | **106770** |
| Operating expenses |  | (78446) | (48331) |
| **Operating profit** | *5* | **46913** | **58439** |
| Finance income | *6* | 2989 | 2992 |
| Finance expenses | *6* | (1431) | (609) |
| **Profit before taxation** |  | **48471** | **60822** |
| Taxation | *7* | (13405) | (16176) |
| **Profit for the period** |  | **35066** | **44646** |
| Attributable to: |  |  |  |
| Equity holders of the parent |  | 35242 | 44840 |
| Non-controlling interests |  | (176) | (194) |
| **Profit for the period** |  | **35066** | **44646** |
| **Other comprehensive income/(loss):** |  |  |  |
| *Items that may be reclassified to the profit or loss:* |  |  |  |
| Exchange gain/(loss) on translation of foreign operations |  | 1999 | (1037) |
| Gain/(loss) recognised on hedging instruments |  | 1064 | (7356) |
| Tax (charge)/credit relating to items that may be reclassified |  | (266) | 1839 |
| **Total comprehensive income for the period** |  | **37863** | **38092** |
| Attributable to: |  |  |  |
| Equity owners of the parent |  | 38012 | 38286 |
| Non-controlling interests |  | (149) | (194) |
| **Total comprehensive income for the period** |  | **37863** | **38092** |

---

The accompanying notes are an integral part of these interim condensed consolidated financial statements.

------

**Interim Condensed Consolidated Statement of Financial Position**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | | | | **As at** | **As at** | **Audited at** |
| | | | | **30 Jun 2025** | **30 Jun 2025** | **31 Dec 2024** |
|  |  | *Note* | *Note* | <br>**£'000** | <br>**£'000** | <br>**£'000** |
| **Non-current assets** | **Non-current assets** |  |  |  |  |  |
| Goodwill | Goodwill |  |  | 4689 | 4689 | 4526 |
| Intangible assets | Intangible assets |  |  | 15092 | 15092 | 14957 |
| Property, plant and equipment | Property, plant and equipment |  |  | 7202 | 7202 | 7670 |
| Right-of-use assets | Right-of-use assets |  |  | 17685 | 17685 | 18993 |
| Derivative financial assets | Derivative financial assets | *9* | *9* | 92226 | 92226 | 28699 |
| **Total non-current assets** | **Total non-current assets** |  |  | **136894** | **136894** | **74845** |
| **Current assets** | **Current assets** |  |  |  |  |  |
| Cash and cash equivalents | Cash and cash equivalents | *11* | *11* | 209881 | 209881 | 252468 |
| Derivative financial assets | Derivative financial assets | *9* | *9* | 240469 | 240469 | 132446 |
| Trade and other receivables  | Trade and other receivables  | *9, 10* | *9, 10* | 13974 | 13974 | 12715 |
| Fixed collateral | Fixed collateral | *11* | *11* | 10302 | 10302 | 10063 |
| Current tax asset | Current tax asset |  |  | - | - | - |
| **Total current assets** | **Total current assets** |  |  | **474626** | **474626** | **407692** |
| **Total assets** | **Total assets** |  |  | **611520** | **611520** | **482537** |
| **Equity** | **Equity** |  |  |  |  |  |
| Share capital | Share capital | *12* | *12* | 87 | 87 | 87 |
| Share premium account | Share premium account |  |  | 52911 | 52911 | 52566 |
| Treasury shares | Treasury shares | *12* | *12* | (28807) | (28807) | (6697) |
| Retained earnings | Retained earnings |  |  | 281188 | 281188 | 235256 |
| Other reserves | Other reserves | *12* | *12* | 10756 | 10756 | (3086) |
| **Equity attributable to equity holders of the parent** | **Equity attributable to equity holders of the parent** | **Equity attributable to equity holders of the parent** |  | **316135** | **316135** | **278126** |
| Non-controlling interests | Non-controlling interests |  |  | 730 | 730 | 879 |
| **Total equity** | **Total equity** |  |  | **316865** | **316865** | **279005** |
| **Current liabilities** | **Current liabilities** |  |  |  |  |  |
| Derivative financial liabilities | 9 | 9 | 95604 | 95604 | 84080 | 84080 |
| Other payables | *13* | *13* | 109862 | 109862 | 45747 | 45747 |
| Redemption liability |  |  | 692 | 692 | - | - |
| Deferred income |  |  | 8837 | 8837 | 8059 | 8059 |
| Lease liability |  |  | 2663 | 2663 | 2180 | 2180 |
| Current tax liability |  |  | 11949 | 11949 | 12086 | 12086 |
| **Total current liabilities** | **Total current liabilities** |  |  | **229607** | **229607** | **152152** |
| **Non-current liabilities** | **Non-current liabilities** |  |  |  |  |  |
| Derivative financial liabilities | Derivative financial liabilities | *9* | *9* | 40060 | 40060 | 24695 |
| Other payables | Other payables | *13* | *13* | 911 | 911 | 885 |
| Redemption liability | Redemption liability |  |  | 1914 | 1914 | 1812 |
| Deferred tax liability | Deferred tax liability | *7* | *7* | 2869 | 2869 | 3661 |
| Lease liability | Lease liability |  |  | 19294 | 19294 | 20327 |
| **Total non-current liabilities** | **Total non-current liabilities** |  |  | **65048** | **65048** | **51380** |
| **Total liabilities** | **Total liabilities** |  |  | **294655** | **294655** | **203532** |
| **Total equity and liabilities** | **Total equity and liabilities** |  |  | **611520** | **611520** | **482537** |

---

The accompanying notes are an integral part of these interim condensed consolidated financial statements.

------

---

| | | | |
|:---|:---|:---|:---|
| **Interim Condensed Consolidated Cash Flow Statement** | | **Six months ended**<br>**30 Jun 2025** | **Six months ended**<br>**30 Jun 2024** |
|  | *Note* | £'000 | £'000 |
| **Cash flows from operating activities** |  |  |  |
| Profit before taxation |  | 48471 | 60822 |
| Net treasury income – client funds |  | (38581) | (41781) |
| Net treasury income – own funds |  | (569) | (664) |
| Finance income | *6* | (2989) | (2992) |
| Finance expense | *6* | 1431 | 609 |
| Amortisation of intangible assets |  | 3275 | 3163 |
| Intangible assets written off |  | 30 | - |
| Depreciation of property, plant and equipment |  | 862 | 923 |
| Depreciation of right-of-use assets |  | 1512 | 1369 |
| (Gain) on disposal of property, plant and equipment |  | - | (1) |
| Share-based payment expense |  | 15621 | 408 |
| Fair value movement of redemption liability |  | (81) | - |
| Decrease/(increase) in other receivables |  | 243 | (457) |
| Increase/(decrease) in other payables and deferred income |  | 64425 | (18829) |
| Increase in derivative financial assets<sup>1</sup> |  | (173648) | (9169) |
| Increase in derivative financial liabilities |  | 30052 | 3077 |
| Increase in fixed collateral |  | (238) | (1540) |
| **Cash (outflows) from operating activities** |  | **(50184)** | **(5062)** |
| Net treasury income received |  | 37649 | 42938 |
| Tax paid |  | (14177) | (15156) |
| **Net cash (outflows)/inflows from operating activities** |  | **(26712)** | **22720** |
| **Cash flows from investing activities** |  |  |  |
| Payments to acquire property, plant and equipment |  | (321) | (215) |
| Proceeds from the sale of property, plant and equipment |  | - | 1 |
| Expenditure on intangible assets |  | (3241) | (4218) |
| Finance income received |  | 2989 | 2992 |
| **Net cash (outflows) from investing activities** |  | **(573)** | **(1440)** |
| **Cash flows from financing activities** |  |  |  |
| Proceeds received on issue/at vesting of share options |  | 1491 | 331 |
| Purchase of treasury shares | *12* | (10295) | (19843) |
| Acquisition of non-controlling interest |  | - | (48) |
| Dividends paid to equity owners of the Parent Company | *8* | (6073) | (5308) |
| Dividends paid to subsidiary shareholders |  | (876) | (1842) |
| Payment of lease liabilities- principal |  | (764) | (838) |
| Payment of lease liabilities- interest |  | (603) | (591) |
| **Net cash (outflows) from financing activities** |  | **(17120)** | **(28139)** |
| **(Decrease) in net cash and cash equivalents in the period** |  | (44405) | (6859) |
| Net cash and cash equivalents at beginning of period |  | 252468 | 197941 |
| Net exchange gain/(loss) |  | 1818 | (1006) |
| **Cash and cash equivalents at end of period** | *11* | **209881** | **190076** |

---

The accompanying notes are an integral part of these interim condensed consolidated financial statements.

<sup>1</sup> The £173.6m cash outflow arising from an increase in derivative financial assets for the six months to 30 June 2025 includes £117.4m relating to an increase in variation margin from (£13.1m) in 2024 to £104.3m (as shown in note 11), £2m relating to MTM on Alpha trades and £25m in unrealised revenue.

------

**Interim Condensed Consolidated Statement of Changes in Equity**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Share capital** | **Share premium account** | **Treasury shares** | **Retained earnings** | **Other reserves** | **Total** | **Non-controlling interests** | **Total** |
| | £'000 | £'000 | £'000 | £'000 | £'000 | £'000 | £'000 | £'000 |
| **Balance at 1 January 2024** | **87** | **52566** | **-** | **170939** | **(632)** | **222960** | **531** | **223491** |
| Profit/(loss) for the period | - | - | - | 44840 | - | 44840 | (194) | 44646 |
| *Other comprehensive expense:* |  |  |  |  |  |  |  |  |
| Losses recognised on hedging instruments | - | - | - | (5517) | - | (5517) | - | (5517) |
| Exchange differences arising on translation of foreign operations | - | - | - | - | (1037) | (1037) | - | (1037) |
| *Transactions with owners:* |  |  |  |  |  |  |  |  |
| Acquisition of NCI | - | - | - | (46) | - | (46) | (2) | (48) |
| Acquisition of treasury shares | - | - | (19843) | - | - | (19843) | - | (19843) |
| Treasury shares issued in relation to subsidiary earnout | - | - | 4024 | (3720) | - | 304 | - | 304 |
| Issue of share options in subsidiary undertakings | - | - | - | 1 | - | 1 | - | 1 |
| Share-based payments | - | - | - | 408 | - | 408 | - | 408 |
| Dividends paid | - | - | - | (7150) | - | (7150) | - | (7150) |
| **Balance at 30 June 2024** | **87** | **52566** | **(15819)** | **199755** | **(1669)** | **234920** | **335** | **235255** |

---

The accompanying notes are an integral part of these interim condensed consolidated financial statements.

------

**Interim Condensed Consolidated Statement of Changes in Equity [cont.]**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Share capital** | **Share premium account** | **Treasury shares** | **Retained earnings** | **Other reserves** | **Total** | **Non-controlling interests** | **Total** |
| | £'000 | £'000 | £'000 | £'000 | £'000 | £'000 | £'000 | £'000 |
| **Balance at 1 January 2025 (audited)** | **87** | **52566** | **(6697)** | **235256** | **(3086)** | **278126** | **879** | **279005** |
| Profit/(loss) for the period | - | - | - | 35242 | - | 35242 | (176) | 35066 |
| *Other comprehensive income:* |  |  |  |  |  |  |  |  |
| Gains recognised on hedging instruments | - | - | - | 798 | - | 798 | - | 798 |
| Exchange differences arising on translation of foreign operations | - | - | - | - | 1972 | 1972 | 27 | 1999 |
| *Transactions with owners:* |  |  |  |  |  |  |  |  |
| Acquisition of treasury shares (refer to note 12) | - | - | (29578) | 19283 | - | (10295) | - | (10295) |
| Treasury shares issued on vesting of option schemes | - | - | 7468 | (6192) | - | 1276 | - | 1276 |
| Shares issued on vesting of share option schemes | -\* | 345 | - | - | - | 345 | - | 345 |
| Share-based payments | - | - | - | 3751 | 11870 | 15621 | - | 15621 |
| Dividends paid | - | - | - | (6949) | - | (6949) | - | (6949) |
| Forfeiture of share options in subsidiary | - | - | - | (1) | - | (1) | - | (1) |
| **Balance at 30 June 2025 (unaudited)** | **87** | **52911** | **(28807)** | **281188** | **10756** | **316135** | **730** | **316865** |

---

\*Share capital issued in the period is below the rounding amount of £1,000 and therefore presented as nil.

The accompanying notes are an integral part of these interim condensed consolidated financial statements.

------

**Notes to the Interim Condensed Consolidated Financial Statements for the six months ended 30 June 2025**

**1. General information**

Alpha Group International Limited (the "Company") is a private company limited by shares. The Company was formerly Alpha Group International plc, a public limited company with shares listed on the Main market of The London Stock Exchange between 2 May 2024 and 3 November 2025. The Company is incorporated and domiciled in the UK (registered number 07262416) and its registered office is Brunel Building, 2 Canalside Walk, London, England, W2 1DG.

The condensed consolidated interim financial statements incorporate the results of the Company and its subsidiary undertakings ("the Group").

**2. Basis of preparation**

These interim condensed consolidated financial statements have been prepared in accordance with IAS 34 Interim Financial Reporting. They do not include all disclosures that would otherwise be required in a complete set of financial statements and should be read in conjunction with the 2024 special purpose consolidated financial statements for the year ended 31 December 2024.

The Directors have prepared these Condensed Consolidated Financial Statements as of and for the six-month period ended 30 June 2025 for the inclusion in a filing on Form 8-K/A with the United States Securities and Exchange Commission by Corpay Inc, as a consequence of the acquisition of the Company's issued share capital by Corpay Inc. (See Note 16 Events after the reporting period), for purposes of the satisfactory of Corpay Inc's regulatory reporting requirements in the United States.

The financial information is presented in Pounds Sterling ("£"), which is the Group's functional currency, and all values are rounded ("£'000") to the nearest thousand except where otherwise indicated.

<br>**Going concern**

The Board has concluded that it is appropriate to adopt the going concern basis, having undertaken a review of financial forecasts and available resources. The Group meets its day-to-day working capital requirements through its strong cash reserves. As at 30 June 2025, the Group had £209.9m of cash and cash equivalents (see note 11), with no debt financing commitments. The Group has net current assets of £245.0m and net assets of £316.9m.

In assessing going concern, management have considered some down-side scenarios where adjusted net cash and collateral was stress tested against collateral requirements to banking counterparties. The assessment considered the impact on the Group's operations, its 2026 budget and internal forecasts to 2027.

In these scenarios, the Group has sufficient liquidity, no external debt, and the availability of mitigating actions that would allow it to meet its financial liabilities as they fall due. These mitigating actions, should they be required, are within management's control.

Corpay invested £1.8bn in the acquisition of Alpha, they have publicly committed to supporting the organic growth of Alpha.

Furthermore, Alpha is now part of Corpay and will benefit from access to greater liquidity and funding sources.

The Directors have a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future. The Group continues to adopt the going concern basis in preparing the condensed consolidated interim financial statements.

------

**2. Basis of preparation (continued)**

**Accounting policies**

The accounting policies adopted by the Group in these interim financial statements are consistent with those applied by the Group in its non-statutory consolidated financial statements for the year ended 31 December 2024.

*New standards, interpretations and amendments effective from 1 January 2025:*

There are no new standards and interpretations which became mandatorily effective for the current reporting period which have had a material effect on the financial statements of the Group.

*New standards, interpretations and amendments not yet effective:*

IFRS 18 Presentation and Disclosure in Financial Statements is effective for annual reporting periods beginning on or after 1 January 2027. The Group has not early adopted IFRS 18.

IFRS 18 introduces revised requirements for the presentation and disclosure of financial performance. The Group is currently assessing the potential impact of IFRS 18 on its interim condensed consolidated financial statements.

**3. Significant accounting estimates and judgements**

The accounting estimates and judgements adopted by the Group in these interim financial statements are consistent with those applied by the Group in its non-statutory consolidated financial statements for the year ended 31 December 2024.

The preparation of the Group's interim financial statements requires management to make estimates, judgements and assumptions about the carrying amounts of assets and liabilities. Uncertainty about these assumptions and estimates could result in outcomes that could require a material adjustment to the carrying amount of the assets or liability affected in the future.

The estimates and underlying assumptions are reviewed on an ongoing basis. In the process of applying the Group's accounting policies, management has made the following judgements and estimates which have the most significant effect on the amounts recognised in the interim financial statements.

**Significant estimates**

*Impairment of financial assets*

An impairment loss is recognised for the amount by which the asset's carrying amount exceeds its recoverable amount. Impairment losses are recognised in the interim condensed consolidated Statement of Comprehensive Income. The Group performs an assessment of significant increase in credit risk on an annual basis, as well as assessing counterparty credit risk on an ongoing basis via the credit value adjustment model. We consider there to be no indication of material change in our credit risk assessment at 30 June 2025.

*Fair value – Credit valuation adjustment*

The credit value adjustment of £4.5m (FY2024: £4.4m) has been calculated by management based on the assumption that the Group will be unable to collect all the receivable amounts due under the contract terms, and therefore, is a method of counterparty credit risk management. In order to calculate expected future cash flows, management make an estimate using the latest real-time market information, forward-looking volatility, credit quality of the borrower and experience.

------

**3. Significant accounting estimates and judgements (continued)**

**Significant judgements**

*Share-based payments – Option fair values*

Equity settled share awards are recognised as an expense based on their fair value at date of grant. The value of these share option schemes are estimated through the use of option valuation models which require an element of judgement in assessing the inputs. Judgement is also exercised in assessing the number of options subject to non-market vesting conditions that will vest. Further details are set out in note 15.

*Carrying value of goodwill attributable to Cobase – estimation of recoverable amount*

Goodwill of £4.7m arose on the acquisition of Financial Transaction Services B.V. (trading as "Cobase") and has been tested for impairment at period end. Recoverable amount has been assessed based on estimates of the fair value less cost to sell. For the period ending 30 June 2025, management have undertaken a review for indicators of impairment and have determined that there is sufficient headroom and therefore no impairment charge has been recognised.

**4. Segmental reporting**

As set out in the consolidated financial statements for the year ended 31 December 2024, the Group evolved its organisational structure from a product centric structure to a client centric structure as was disclosed for the year ended 31 December 2024.

These segments align with the management accountabilities for performance management and the basis for internal financial reporting and represent our reportable segments. These three segments are explained further as below:

**Corporate:** Alpha's corporate division operates from its own UK HQ (consisting of sales and operations), and seven additional international sales offices in the Netherlands, Spain, Italy, Germany, Austria, Australia, and Canada. Revenues are derived from the provision of market risk management services to corporates across more than 50 countries, covering foreign exchange exposure and, more recently, interest rates and commodities.

**Private Markets:** Alpha's private markets division operates from its own UK HQ (consisting of sales and operations) and two additional operations offices in Luxembourg and Malta. Revenues are derived from the provision of FX risk management, accounts and payments, and fund finance services to private market firms.

**Cobase:** Cobase is a treasury-focused technology platform acquired by the Group in December 2023. Based in Amsterdam, the company provides bank connectivity technologies that enable businesses to manage their banking relationships, accounts and transaction activity all in one place. Revenues are derived from platform usage and annual subscription fees.

The chief operating decision makers, being the Group's Chief Executive Officer and the Chief Financial Officer, monitor the results of the operating segments separately each month. Key measures used to evaluate performance are revenue, and underlying profit before taxation. Management believe that these measures are the most relevant in evaluating the performance of the segment and for making resource allocation decisions.

The Corporate division has overseas offices in Australia, Canada, Netherlands, Italy, Spain, Germany and Austria. These offices contributed aggregate revenue of £25.1m (HY24: £12.3m, FY24: £27.2m). A small component of Private Markets costs arise in Luxembourg, and the profit related to the Malta office has been allocated between the various European entities it supports.

------

**4. Segmental reporting (continued)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Six months ended 30 June 2025** | **Corporate** | **Private Markets** | **Cobase** | **Total** |
| | **£'000** | **£'000** | **£'000** | **£'000** |
| Risk Management\* | 50094 | 14224 | - | 64318 |
| Accounts & Payments\*\* | - | 19826 | - | 19826 |
| Platform fees | - | - | 2065 | 2065 |
| **Total revenue** | **50094** | **34050** | **2065** | **86209** |
| Net treasure income – own funds | 569 | - | - | 569 |
| **Segment income** | **50663** | **34050** | **2065** | **86778** |
| Operating costs | (30918) | (27651) | (2645) | (61214) |
| **Underlying operating profit** | **19745** | **6399** | **(580)** | **25564** |
| Finance income | 2938 | 51 | - | 2989 |
| Finance costs | (180) | (440) | (2) | (622) |
| **Underlying profit before taxation** | **22503** | **6010** | **(582)** | **27931** |
| *Underlying profit before taxation margin* | *45 %* | *18 %* | *-28 %* | *32 %* |
| Net treasure income – client funds | 2107 | 36474 | - | 38581 |
| Non-underlying items\*\*\* |  |  |  | (18041) |
| **Profit before taxation** |  |  |  | **48471** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Six months ended 30 June 2024 - Represented**<sup>1</sup> | **Corporate** | **Private Markets** | **Cobase** | **Total** |
| | **£'000** | **£'000** | **£'000** | **£'000** |
| Risk Management\* | 29783 | 14207 | - | 43990 |
| Accounts & Payments\*\* | - | 19072 | - | 19072 |
| Platform fees | - | - | 1263 | 1263 |
| **Total revenue** | **29783** | **33279** | **1263** | **64325** |
| Net treasure income – own funds | 664 | - | - | 664 |
| **Segment income** | **30447** | **33279** | **1263** | **64989** |
| Operating costs | (18904) | (23471) | (2687) | (45062) |
| **Underlying operating profit** | **11543** | **9808** | **(1424)** | **19927** |
| Finance income | 2992 | - | - | 2992 |
| Finance costs | (221) | (388) | - | (609) |
| **Underlying profit before taxation** | **14314** | **9420** | **(1424)** | **22310** |
| *Underlying profit before taxation margin* | *48 %* | *28 %* | *(113) %* | *35 %* |
| Net treasure income – client funds | 1973 | 39808 | - | 41781 |
| Non-underlying items\*\*\* |  |  |  | (3269) |
| **Profit before taxation** |  |  |  | **60822** |

---

<sup>1</sup> The 30 June 2024 comparatives have been represented to align to the revised organisational structure as was adopted in the year ending 31 December 2024.

\*Risk management represents revenue derived from forward, spot, and option contracts provided to corporate and private market clients, primarily for the purpose of hedging commercial foreign exchange exposures.

\*\*Accounts & Payments represents revenues derived from fees and foreign exchange spot contracts generated from the provision of cross border payments, annual account fees, as well as Fund Finance advisory fees.

\*\*\* Non-underlying items in the period are made up of the below charges and net treasury income - client funds:

------

**4. Segmental reporting (continued)**

---

| | | |
|:---|:---|:---|
| | Six months | Six months |
| | ended | ended |
| | 30 Jun 2025 | 30 Jun 2024 |
| | £'000 | £'000 |
| *Non-underlying items in operating expenses* |  |  |
| Amortisation of purchased intangible assets | 41 | 43 |
| Share-based payments charge – existing schemes | 3751 | 408 |
| Share-based payments charge – Founder Incentive Scheme | 11870 | - |
| Advisor fees relating to Corpay offer | 1650 | - |
| Acquisition costs in relation to business combinations | - | 99 |
| Costs associated with the Company's move from AIM to Main market | - | 2719 |
| Redemption liability – fair value movement | (80) | - |
| **Total non-underlying items in operating expenses** | **17232** | **3269** |
| *Non-underlying items in finance expenses* |  |  |
| Redemption liability – discount unwind | 809 | - |
| **Total non-underlying items** | **18041** | **3269** |

---

**5. Operating profit**

Operating profit is stated after charging/(crediting):

---

| | | |
|:---|:---|:---|
| | Six months ended 30 Jun 2025<br>£'000 | Six months ended<br>30 Jun 2024<br>£'000 |
| Staff costs | 55105<sup>1</sup> | 23991 |
| Depreciation of owned property, plant and equipment | 862 | 923 |
| Amortisation of internally generated intangible assets | 3425 | 3120 |
| Depreciation of right-of-use assets | 1512 | 1369 |
| Rental cost of short-term leases | 389 | 622 |
| Property, plant and equipment written (back)/off | - | (1) |
| Impairment of intangible assets | 30 | - |
| Bad debt expense | 538 | 487 |
| Net foreign exchange (gains)/losses | (776) | 90 |

---

<sup>1</sup> In the six months ending 30 June 2025, staff costs includes a non-cash charge of £11.9m relating to the Founder Incentive Scheme (refer to note 15 for further details on this scheme). This share-based payment charge is non-dilutive as Morgan Tillbrook (Founder and, until 1 January 2025, CEO) will provide/has already provided the shares to fund the arrangements.

------

**6. Finance income and expenses**

---

| | | |
|:---|:---|:---|
| | Six months ended<br>30 Jun 2025<br>£'000 | Six months ended<br>30 Jun 2024<br>£'000 |
| **Finance income** |  |  |
| Interest on bank deposits | 2913 | 2927 |
| Other interest receivable | 76 | 65 |
| **Total** | **2989** | **2992** |
| **Finance costs** |  |  |
| Finance expense on dilapidation provision | (19) | (17) |
| Finance expense on lease liabilities | (603) | (592) |
| Discount unwind on redemption liability<sup>1</sup> | (809) | - |
| **Total** | **(1431)** | **(609)** |

---

<sup>1</sup> On acquisition of Financial Transaction Services B.V. (Cobase) in December 2023, the Group recognised a liability of £1.9m, comprising the fair value of the consideration payable to the non-controlling interests at that time, under the terms of put and call options entered into. The interests are to be acquired in four tranches between 31 December 2025 and 31 December 2029 with pricing based tied to trailing revenue and profitability measures. The Group has updated its assessment of the fair value of the consideration payable as an operating expense, as well as reflecting an unwind of the discount to reflect time value of money through finance expense. On the basis that the fair value assessment and discount unwind are associated with the Cobase acquisition and are not representative of in-period trading.

At 30 June 2025 the redemption liability relating to the acquisition of Cobase has been revalued to £2.6m in the balance sheet and as such a fair value movement has been recognised in operating expenses. Additionally, as the liability approaches its settlement dates, the time value of money is recognised as a finance cost. This reflects the unwinding of the discount on the liability over time, increasing the liability to its settlement amount.

**7. Taxation** 

**Tax charge**

---

| | | |
|:---|:---|:---|
| | Six months<br>ended<br>30 Jun 2025<br>£'000 | Six months<br>ended<br>30 Jun 2024<br>£'000 |
| **Current tax:** |  |  |
| UK Corporation tax on profit for period | 13143 | 15556 |
| Adjustments relating to prior years | 18 | 1 |
| Incremental Overseas Corporation tax on the profit for the period | 1309 | 385 |
| **Total current tax** | **14470** | **15942** |
| **Deferred Tax** |  |  |
| Origination and reversal of temporary differences | (1065) | 234 |
| **Total deferred tax** | **(1065)** | **234** |
| **Total tax expense** | **13405** | **16176** |

---

------

**7. Taxation (continued)**

**Deferred Tax**

---

| | | |
|:---|:---|:---|
| | Six months<br>ended<br>30 Jun 2025<br>£'000 | Six months<br>ended<br>30 Jun 2024<br>£'000 |
| **Deferred tax:** |  |  |
| At 1 January | (3661) | (5305) |
| UK tax charge/(credit) relating to current period from continuing operations | 1065 | (297) |
| UK tax charge relating to acquired operations | - | 63 |
| Tax credit relating to foreign exchange rate movements | (7) | - |
| Tax (credit)/charge on other comprehensive income | (266) | 1839 |
| **Total deferred tax liability** | **(2869)** | **(3700)** |

---

The Group's effective tax rate at 30 June 2025 was 27.6% (30 June 2024: 26.6%). The increase is predominately due to the Founder Incentive scheme share-based payment charges and acquisition legal costs for which there is no tax deduction for the accounting charges. A tax deduction, determined with reference to the market value of the shares will arise in relation to the Founder Incentive Scheme on participant exercise, subject to vesting criteria being met.

**8. Dividends**

---

| | | |
|:---|:---|:---|
| | Six months | Six months |
| | ended | ended |
| | 30 Jun 2025 | 30 Jun 2024 |
| | £'000 | £'000 |
| Final plc dividend for the year ended 31 December 2023 of 12.3p per share | - | 5308 |
| Final plc dividend for the year ended 31 December 2024 of 14.0p per share | 6073 | - |
|  | 6073 | 5308 |

---

All dividends paid are in respect of the ordinary shares of £0.002 each.

In addition to the dividends paid to ordinary shareholders of the Group shown above, the Condensed Consolidated Statement of Changes in Equity includes £876k (H1 2024: £1,842k) of dividends paid to subsidiary shareholders.

The Directors do not intend to declare an interim dividend in September 2025.

As was set out in the financial statements for the year ended 31 December 2024, the Company identified that the interim dividend for the year ended 31 December 2024 (£1.8m) and the interim dividends paid on 13 October 2017 and on 8 October 2021 (together £0.7m) were made otherwise than in accordance with the UK Companies Act 2006. During the first half of 2025, the Group took steps to resolve the historic unlawful distributions, these are set out in note 12.

------

**9. Financial instruments**

*Fair value measurement*

Forward and option contracts fall into level 2 of the fair value hierarchy**.** Level 2 comprises those financial instruments which can be valued using inputs other than quoted prices that are observable for the asset or liability either directly (i.e., prices) or indirectly (i.e., derived from prices). The fair value of forward exchange contracts is measured using observable forward exchange rates for contracts with a similar maturity at the reporting date. The fair value of option foreign exchange contracts is measured using an industry standard external model that best presents the unpublished interbank valuations. The fair value of interest rate contracts is measured using observable interest rates for contracts with a similar maturity at the reporting date.

The fair value measurement applied in these interim financial statements are consistent with those applied by the Group in its consolidated financial statements for the year ended 31 December 2024.

There were no transfers between level 1 and 2 during the current or prior period. The fair value of all other financial assets and financial liabilities is approximate to their carrying value.

**10. Trade and other receivables**

---

| | | |
|:---|:---|:---|
| | 30 Jun 2025 | 31 Dec 2024 |
| **Current:** | £'000 | £'000 |
| Trade receivables | 3952 | 4041 |
| Other receivables | 6039 | 4926 |
| Prepayments | 3983 | 3748 |
| **Total** | **13974** | **12715** |

---

Trade receivables consist of invoices owed from clients. Other receivables consist primarily of accrued interest, and rental deposits. The carrying value of receivables classified as financial assets measured at amortised cost, approximates fair value.

**11. Cash** 

Cash and cash equivalents comprise cash balances and deposits held at call with banks for which the Group has immediate access.

Fixed collateral comprises cash held as collateral with banking counterparties for which the Group does not have immediate access.

Cash balances included within derivative financial assets relate to the variation margin called by banking counterparties for which the Group does not have immediate access.

---

| | | |
|:---|:---|:---|
| | 30 Jun 2025 | 31 Dec 2024 |
| | £'000 | £'000 |
| Cash and cash equivalents | 209881 | 252468 |
| Variation margin<sup>1</sup> | 101962 | (14333) |
| Fixed collateral | 10302 | 10063 |
| **Total cash** | **322145** | **248198** |

---

<sup>1</sup> As noted in the condensed consolidated statement of cash flows, derivative assets increased principally as a result of cash outflows in the 6 months to 30 June 2025 reflecting higher collateral calls from banking counterparties in excess of collateral posted with Alpha by clients. The balance of margin calls changes on a daily basis and can in periods of heightened volatility result in a widening of the balances between our banking counterparties and our clients.

------

**12. Capital and reserves**

The following movements of share capital occurred in the 6 months to 30 June 2025:

---

| | | | |
|:---|:---|:---|:---|
| | Ordinary shares | Share capital | Treasury shares |
| | No. | £'000 | £'000 |
| As at 1 January 2025 - shares of £0.002 each | 43031668<sup>1</sup> | 87 | (6697) |
| Effect of remediation of treasury share acquisition in 2024 otherwise than in accordance with UK Companies Act 2006 (UK CA '06) | (919945) | - | (19283)<sup>2</sup> |
| Acquisition of treasury shares in 2025 otherwise than in accordance with UK CA '06 and subsequent remediation | (143611) | - | (3476) |
| Acquisition of treasury shares in accordance with UK CA '06 | (254181) | - | (6819) |
|  | **41713931** | **87** | **(36275)** |
| Transfer of shares from treasury on vesting of share option schemes | 340676 | - | 7468 |
| New shares issued on vesting of share option schemes | 250000 | -<sup>3</sup> | - |
| **As at 30 June 2025** | **42304607** | **87** | **(28807)** |

---

<sup>1</sup> Excluding the effect of the acquisition of treasury shares other than in accordance with CA '06 in the course of 2024, shares in issue at 1 January 2025 were 42,111,723.

<sup>2</sup> £19.3m debit to Treasury shares from retained earnings arises from the correction of the unlawful buybacks as explained below.

<sup>3</sup> Share capital issued in the period is below the rounding amount of £1,000 and therefore presented as nil.

As set out in the 2024 Annual Report, during the year ended 31 December 2024, repurchases of 919,945 shares for which an aggregate amount of £19.3m was paid were made otherwise than in accordance with the Companies Act 2006, due to insufficient reserves being available at the time the repurchases were made. Additionally, during the period 1 January 2025 to 12 March 2025 the Group similarly repurchased 143,611 shares for some £3.5m otherwise than in accordance with the Act.

Other reserves are made up of the following balances:

---

| | | |
|:---|:---|:---|
| | 30 Jun 2025 | 31 Dec 2024 |
| | £'000 | £'000 |
| Capital redemption reserve | 4 | 4 |
| Capital contribution reserve<sup>1</sup> | 11870 | - |
| Merger reserve | 667 | 667 |
| Redemption reserve | (1884) | (1884) |
| Translation reserve | 99 | (1873) |
| **Total** | **10756** | **(3086)** |

---

<sup>1</sup> For further information refer to note 15.

During the period under review, and prior to the Corpay acquisition, the Board maintained a progressive dividend policy, coupled with the execution of value-capped share buybacks, retaining and deploying our remaining cash to grow the business.

------

**13. Other payables**

---

| | | |
|:---|:---|:---|
| | 30 Jun 2025 | 31 Dec 2024 |
| | £'000 | £'000 |
| **Current:** |  |  |
| Other payables | 102105 | 35735 |
| Other taxation and social security | 1571 | 1340 |
| Accruals | 6186 | 8672 |
|  | **109862** | **45747** |
| **Non-current:** |  |  |
| Provisions | 911 | 885 |
|  | **911** | **885** |
| **Total other payables** | **110773** | **46632** |

---

Other payables consists of margin received from clients. The carrying value of other payables classified as financial liabilities measured at amortised cost, approximates fair value.

**14. Related party transactions and balances**

Parties are considered to be related if one party has the ability to control the other party or exercise significant influence over the other party in making financial or operational decisions, or one other party controls both.

**Subsidiaries**

The Parent company of the Group is Alpha Group International Limited.

During the period, one new subsidiary has been established, Alpha Group International Inc in Delaware.

Transactions between the Group and its subsidiaries have been eliminated on consolidation and are not disclosed in this note.

<u>Transactions with key management personnel</u> 

Key management personnel are considered to be the members of the Board and the Executive Committee who served during the period. These individuals received remuneration/emoluments including share incentive arrangement awards (detailed further in note 15 below), at arm's length and in line with contractual arrangements.

At 30 June, the Group's CEO, Clive Kahn owed the Company £22,803 following the Company's under estimation of tax due on the disbursement of awards in respect of the Founders Incentive Scheme in February 2025. This amount was repaid in full in November 2025. There were no other balances owed to or owed from related parties at 30 June 2025 or 30 June 2024.

**15. Share-based payments**

During the period the Group recognised a total share-based payment expense in the condensed consolidated statement of comprehensive income of £15.6m (six months ended 30 June 2024: £0.4m), of which £11.9m related to the newly introduced Founder Incentive Scheme.

The Group operates the same equity-settled share-based payment arrangements as reported at 31 December 2024 with the exception of two new schemes introduced during the period.

------

**15. Share-based payments (continued)**

**Founder Incentive Scheme**

On 12 February 2025, the Group announced that Morgan Tillbrook, founder and former CEO of Alpha had pledged 1,103,555 ordinary shares of 0.2p each in Alpha from his personal holding with a total value of approximately £28m (based on the closing share price of £25.40 on 11 February 2025) to members of the senior leadership team to both thank them for historic performance and incentivise them for future performance. This announcement followed formal approval by the Company's Remuneration Committee on 11 February.

These arrangements met the definition of an equity settled share-based payment scheme under IFRS 2 Share-based payments and are treated as such. The fair value of the awards was deemed to be the market value of the shares subject to awards at the date of issue.

Circa £6.4m of the charge incurred in the six months ended 30 June 2025 relates to the fully vested nil cost options awarded to the Non-Executive Directors and Clive Kahn, which have been charged to the statement of comprehensive income with a credit to the capital contribution reserve. Charges associated with other awards were then calculated based on being amortised over the 36-month performance period from 12 February 2025, subject to performance conditions outlined below.

As Morgan Tillbrook will provide/has already provided the shares to fund the arrangements (and has formally committed to this pledge through the execution of a linking agreement and by holding the relevant Shares in a nominee account established for this purpose), these awards will not create any dilution of other shareholders' interests. Furthermore, recipients will bear the associated employers' NIC charge.

**Spain**

During the period, the Group implemented a new share scheme to incentivise a small number of key personnel of the Spanish branch of Alpha FX Europe Limited. The awards when granted were subject to performance conditions and intended to vest between 31 December 2025 and 31 December 2027. The charge in the period for this scheme was £0.2m.

**16. Events after the reporting period**

**Awards under Group LTIP Scheme**

On 25 August 2025 and in accordance with the Group Remuneration Policy which was approved at the AGM in May 2025, Tim Powell (CFO) and Tim Butters (CRO) were granted awards of 23,657 and 11,296 shares, respectively under the Group Long-Term Incentive Plan (LTIP).

**Acquisition by Corpay Inc.** 

On 23 July 2025, it was announced that the Board of Directors of Alpha Group International Limited and Corpay Inc. had reached an agreement on the terms of a recommended cash acquisition of the entire issued and to be issued ordinary share capital of Alpha by Corpay, by means of a Court approved Scheme of Arrangement.

On 2 September 2025, shareholder approval for the both the acquisition and the proposed Scheme of Arrangement were obtained following a Court meeting and a general meeting.

On 31 October 2025, and following receipt of the necessary regulatory approvals, 100% of the outstanding share capital of Alpha Group International plc (i.e. all shares other than those held in treasury) was acquired by US-based Corpay Inc. for headline consideration of circa £1.8bn ($2.3bn).

The ultimate controlling party as at the date of approval of these financial statements is Corpay Inc.

------

**16. Events after the reporting period (continued)**

As part of the acquisition, all relevant individuals holding options or rights to share awards yet to vest under the Group's various equity incentive schemes (including the Executive LTIP Scheme and the Founder Incentive Scheme) reached agreement with the Company to surrender all future rights under these schemes in return for fixed cash and, in certain cases, equity awards which immediately vested. All equity vestings were subsequently acquired by Corpay in exchange for a fixed sum of cash paid to the individuals.

In aggregate the total amount of cash owing to the relevant individuals was £35m, considered part of the acquisition consideration. The majority of these payments owing to the relevant individuals was made in November 2025, although a proportion of proceeds owing to certain individuals have been deferred for a year and remain subject to certain conditions, principally continuing service within the Corpay Group. Further details of these transactions will be included in the Company's 2025 financial statements.

Also as part of the acquisition, the Group acquired the remaining non-controlling interest in Cobase for circa £2m.

On 31 October 2025, the Chairman and all other non-Executive Directors stood down from the Board. On 5 November 2025, Alpha Group International Plc, which was formerly registered as a public company, was re-registered as a private company limited by shares under the name of Alpha Group International Ltd.

## Exhibit 99.3

**Exhibit 99.3**

**UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION**

The following unaudited pro forma condensed combined financial statements and notes thereto have been prepared in accordance with Article 11 Regulation S-X as promulgated by the U.S. Securities and Exchange Commission (the "SEC"), as amended by the final rule Release No. 33-10786 "Amendments to Financial Disclosures about Acquired and Disclosed Businesses," and FASB Accounting Standards Codification Topic 805 (ASC 805) in order to give effect to the Acquisition (see below) and the related transaction accounting adjustments (pro forma adjustments) described in the accompanying notes.

On October 31, 2025, Corpay, Inc. ("Corpay" or the "Company") completed the acquisition of 100% of the ordinary shares of Alpha Group International plc (LSE: ALPHA) ("Alpha") for £42.50 in cash for each Alpha share, resulting in an aggregate purchase price of approximately £1.8 billion (U.S. $2.4 billion) (the "Acquisition"). The consideration for the transaction was paid using cash provided primarily by incremental borrowings under Corpay's Credit Agreement, namely a new seven-year, $900 million Term Loan B and an incremental Revolver B borrowing of $1 billion under its existing revolving line of credit facility. The acquisition was effected by means of a court-sanctioned scheme of arrangement under Part 26 of the United Kingdom Companies Act 2006. Alpha is a leading provider of business-to-business cross-border foreign exchange solutions to corporations and investment funds in the United Kingdom ("UK") and Europe.

The unaudited pro forma condensed combined statements of income for the six months ended June 30, 2025 and for the year ended December 31, 2024 are presented as if the Acquisition had occurred on January 1, 2024. The unaudited pro forma condensed combined balance sheet as of June 30, 2025 is presented as if the Acquisition occurred on that date.

The unaudited pro forma condensed combined financial information do not purport to represent Corpay's actual consolidated financial position had the Acquisition occurred on June 30, 2025 or represent the results of operations that would have occurred had the balance sheet pro forma adjustments occurred on January 1, 2024. Nor do the unaudited pro forma condensed combined financial statements project Corpay's financial position as of any future date or results of operations for any future periods.

The total estimated purchase price consideration and related preliminary purchase price allocations for the Acquisition have not yet been finalized. The preliminary fair values of the assets acquired and liabilities assumed and the related acquisition accounting adjustments incorporated into the unaudited pro forma condensed combined financial statements are based on information available and certain estimates and assumptions that management believes are reasonable.

The unaudited pro forma purchase price adjustments and the purchase price allocation are subject to change during the measurement period (no longer than twelve months from acquisition date) as the Company finalizes the valuations of net tangible and intangible assets and other working capital accounts. The preliminary unaudited pro forma purchase price adjustments have been made solely for the purpose of providing the unaudited pro forma condensed combined financial statements. Actual amounts recorded in connection with the Acquisition may differ from those from those reflected in the unaudited pro forma condensed combined financial statements due to changes in the estimated fair values of the assets acquired and liabilities assumed upon completion of the final valuation analysis. The assumptions and estimates are described in the accompanying notes.

Certain reclassification adjustments have been made in the presentation of Alpha's historical amounts to conform the Alpha financial statements to the presentation followed by the Company as further described in the accompanying notes.

------

The following unaudited pro forma condensed combined statements of income for the year ended December 31, 2024 and the six months ended June 30, 2025 and the unaudited pro forma condensed combined balance sheet as of June 30, 2025, are based on the historical financial statements of Corpay and Alpha after giving effect to the Acquisition and applying the assumptions and adjustments described herein.

The unaudited pro forma condensed combined financial information, including the notes thereto, are qualified in their entirety by reference to, and have been derived from and should be read in conjunction with, the Company's historical consolidated financial statements included in its Annual Report on Form 10-K for the year ended December 31, 2024, and its Forms 10-Q for the quarter ended June 30, 2025, and Alpha's historical consolidated financial statements and related notes for the year ended December 31, 2024 and as of and for the six months ended June 30, 2025, included as Exhibits 99.2 and 99.3 to this Current Report on Form 8-K/A and are incorporated by reference herein.

------

**UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF INCOME**

**FOR THE YEAR ENDED DECEMBER 31, 2024**

*(In Thousands)*

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Corpay, Inc. and Subsidiaries Historical <br>(in USD)** | **Alpha Historical** <br>**(in GBP)**<sup>1</sup> | **Alpha Historical** <br>**(in USD)**<sup>1</sup> | **Pro Forma Adjustments <br>(in USD)** | | **Pro Forma Combined <br>(in USD)** |
| Revenues, net | $3974589 | £135600 | $173301 | $109020 | **(A)** | $4256910 |
| Net treasury income - client funds |  | 83996 | 107349 | (107349) | **(A)** |  |
| Net treasury income - own funds |  | 1307 | 1670 | (1670) | **(A)** |  |
| Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating expenses |  | 102608 | 131136 | (131136) | **(A)** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Processing | 869085 |  |  | 62343 | **(A)** | 931428 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Selling | 380906 |  |  | 20789 | **(A)** | 401695 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 616874 |  |  | 137173 | **(A)(C)(D)** | 754047 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 351088 |  |  | 92362 | **(A)(B)(C)** | 443450 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Goodwill impairment | 90000 |  |  |  |  | 90000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other operating, net | 789 |  |  |  |  | 789 |
| Gain on disposition of business | (121310) |  |  |  |  | (121310) |
| Operating income | 1787157 | 118295 | 151184 | (181530) |  | 1756811 |
| Investment loss, net | 239 |  |  |  |  | 239 |
| Other expense, net | 13722 |  |  |  |  | 13722 |
| Finance income |  | (6053) | (7736) | 7736 | **(A)** |  |
| Finance expenses |  | 1234 | 1577 | (1577) | **(A)** |  |
| Interest expense, net | 383043 |  |  | 104395 | **(A)(C)(E)** | 487438 |
| Loss on extinguishment of debt | 5040 |  |  |  |  | 5040 |
| Total other expenses, net | 402044 | (4819) | (6159) | 110554 |  | 506439 |
| Income before income taxes | 1385113 | 123114 | 157343 | (292084) |  | 1250372 |
| Provision for income taxes | 381381 | 30389 | 38838 | (75060) | **(G)** | 345159 |
| Net income | 1003732 | 92725 | 118505 | (217024) |  | 905213 |
| Less: Net loss attributable to noncontrolling interest | (14) | (294) | (376) | 376 | **(F)** | (14) |
| Net income attributable to Parent | $1003746 | £93019 | $118881 | $(217400) |  | $905227 |
| Earnings per share: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic earnings per share attributable to Corpay | $14.27 |  |  |  |  | $12.87 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted earnings per share attributable to Corpay | $13.97 |  |  |  |  | $12.60 |
| Weighted average shares outstanding: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic shares | 70331 |  |  |  |  | 70331 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted shares | 71848 |  |  |  |  | 71848 |

---

<sup>1</sup> Reflects the translation of the historical results of Alpha from GBP to USD using an average spot rate of 1.2780 for the year ended December 31, 2024.

------

**UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF INCOME**

**FOR THE SIX MONTHS ENDED JUNE 30, 2025**

*(In Thousands)*

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Corpay, Inc. and Subsidiaries Historical <br>(in USD)** | **Alpha Historical** <br>**(in GBP)**<sup>1</sup> | **Alpha Historical** <br>**(in USD)**<sup>1</sup> | **Pro Forma Adjustments <br>(in USD)** | | **Pro Forma Combined <br>(in USD)** |
| Revenues, net | $2107697 | £86209 | $111839 | $50789 | **(A)** | $2270325 |
| Net treasury income - client funds |  | 38581 | 50051 | (50051) | **(A)** |  |
| Net treasury income - own funds |  | 569 | 738 | (738) | **(A)** |  |
| Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating expenses |  | 78446 | 101768 | (101768) | **(A)** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Processing | 460361 |  |  | 38361 | **(A)** | 498722 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Selling | 223334 |  |  | 15632 | **(A)** | 238966 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 333953 |  |  | 46010 | **(A)(C)(D)** | 379963 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 183538 |  |  | 46851 | **(A)(B)(C)** | 230389 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other operating, net | (3) |  |  |  |  | (3) |
| Operating income | 906514 | 46913 | 60860 | (45086) |  | 922288 |
| Other income, net | (6477) |  |  |  |  | (6477) |
| Finance income |  | (2989) | (3878) | 3878 | **(A)** |  |
| Finance expenses |  | 1431 | 1856 | (1856) | **(A)** |  |
| Interest expense, net | 190794 |  |  | 49096 | **(A)(C)(E)** | 239890 |
| Loss on extinguishment of debt | 1596 |  |  |  |  | 1596 |
| Total other expenses, net | 185913 | (1558) | (2022) | 51118 |  | 235009 |
| Income before income taxes | 720601 | 48471 | 62882 | (96204) |  | 687279 |
| Provision for income taxes | 192648 | 13405 | 17390 | (24722) | **(G)** | 185316 |
| Net income | 527953 | 35066 | 45492 | (71482) |  | 501963 |
| Less: Net income (loss) attributable to noncontrolling interest | 552 | (176) | (228) | 228 | **(F)** | 552 |
| Net income attributable to Parent | $527401 | £35242 | $45720 | $(71710) |  | $501411 |
| Earnings per share: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic earnings per share attributable to Corpay | $7.49 |  |  |  |  | $7.12 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted earnings per share attributable to Corpay | $7.38 |  |  |  |  | $7.01 |
| Weighted average shares outstanding: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic shares | 70432 |  |  |  |  | 70432 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted shares | 71494 |  |  |  |  | 71494 |

---

<sup>1</sup> Reflects the translation of the historical results of Alpha from GBP to USD using an average spot rate of 1.2973 for the six months ended June 30, 2025.

------

**UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET**

**AS OF JUNE 30, 2025**

*(In Thousands)*

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Corpay, Inc. and Subsidiaries Historical <br>(in USD)** | **Alpha Historical**<br> **(in GBP)**<sup>1</sup> | **Alpha Historical**<br> **(in USD)**<sup>1</sup> | **Pro Forma Adjustments <br>(in USD)** | | **Pro Forma Combined <br>(in USD)** |
| **Assets** | | | | | | |
| Current assets: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $2192849 | £209881 | $287833 | $(646642) | **(O)(P)(Q)** | $1834040 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restricted cash | 3338509 |  |  | 3901828 | **(H)(I)** | 7240337 |
| &nbsp;&nbsp;&nbsp;&nbsp;Derivative financial assets |  | 240469 | 329782 | (329782) | **(H)** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net | 2601292 | 13974 | 19164 |  |  | 2620456 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed collateral |  | 10302 | 14128 | (14128) | **(H)** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Securitized accounts receivable—restricted for securitization investors | 1639000 |  |  |  |  | 1639000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 987593 |  |  | 277230 | **(H)(I)** | 1264823 |
| Total current assets | 10759243 | 474626 | 650907 | 3188506 |  | 14598656 |
| Property and equipment, net | 434319 | 7202 | 9877 |  |  | 444196 |
| Goodwill | 6334018 | 4689 | 6431 | 1283310 | **(J)(K)(L)(M)(O)** | 7623759 |
| Other intangibles, net | 2372305 | 15092 | 20697 | 1016637 | **(L)(M)** | 3409639 |
| Investments | 58319 |  |  |  |  | 58319 |
| Right-of-use assets |  | 17685 | 24253 | (24253) | **(H)** |  |
| Derivative financial assets |  | 92226 | 126480 | (126480) | **(H)** |  |
| Other assets | 477022 |  |  | 160796 | **(H)(I)(J)(P)(O)** | 637818 |
| Total assets | $20435226 | £611520 | $838645 | $5498516 |  | $26772387 |
| **Liabilities and equity** |  |  |  |  |  |  |
| Current liabilities: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | $1974528 | £— | $— | $— |  | $1974528 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses | 450207 |  |  | 58210 | **(N)** | 508417 |
| &nbsp;&nbsp;&nbsp;&nbsp;Customer deposits | 4143205 |  |  | 3747869 | **(I)** | 7891074 |
| &nbsp;&nbsp;&nbsp;&nbsp;Securitization facility | 1639000 |  |  |  |  | 1639000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current portion of notes payable and lines of credit | 609617 |  |  | 1000000 | **(P)** | 1609617 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other current liabilities | 823212 |  |  | 358912 | **(H)(I)(J)(K)** | 1182124 |
| &nbsp;&nbsp;&nbsp;&nbsp;Derivative financial liabilities |  | 95604 | 131112 | (131112) | **(H)** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other payables |  | 109862 | 150666 | (150666) | **(H)** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Redemption liability |  | 692 | 949 | (949) | **(H)** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income |  | 8837 | 12119 | (12119) | **(H)** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Lease liability |  | 2663 | 3652 | (3652) | **(H)** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Current tax liability |  | 11949 | 16387 | (16387) | **(H)** |  |
| Total current liabilities | 9639769 | 229607 | 314885 | 4850106 |  | 14804760 |
| Notes payable and other obligations, less current portion | 5869083 |  |  | 889049 | **(P)** | 6758132 |
| Deferred income taxes | 379240 |  |  | 270509 | **(H)(M)** | 649749 |
| Other noncurrent liabilities | 579955 |  |  | 107130 | **(H)(I)(J)(K)** | 687085 |
| Derivative financial liabilities |  | 40060 | 54939 | (54939) | **(H)** |  |
| Other payables |  | 911 | 1249 | (1249) | **(H)** |  |
| Redemption liability |  | 1914 | 2625 | (2625) | **(H)** |  |
| Deferred tax liability |  | 2869 | 3935 | (3935) | **(H)** |  |

---

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| Lease liability |  | 19294 | 26460 | (26460) | **(H)** |  |
| Total noncurrent liabilities | 6828278 | 65048 | 89208 | 1177480 |  | 8094966 |
| Commitments and contingencies |  |  |  |  |  |  |
| Stockholders' equity: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Share capital |  | 87 | 119 | (119) | **(K)** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Share premium account |  | 52911 | 72563 | (72563) | **(K)** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other reserves |  | 10756 | 14751 | (14751) | **(K)** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock | 132 |  |  |  |  | 132 |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 3902867 |  |  |  |  | 3902867 |
| &nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 9723806 | 281188 | 385624 | (480142) | **(K)(N)(Q)(O)** | 9629288 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (1436386) |  |  |  |  | (1436386) |
| &nbsp;&nbsp;&nbsp;&nbsp;Less treasury stock | (8261846) | (28807) | (39506) | 39506 | **(K)** | (8261846) |
| Total stockholders' equity | 3928573 | 316135 | 433551 | (528069) |  | 3834055 |
| Noncontrolling interest | 38606 | 730 | 1001 | (1001) | **(K)** | 38606 |
| Total equity  | 3967179 | 316865 | 434552 | (529070) |  | 3872661 |
| Total liabilities and equity | $20435226 | £611520 | $838645 | $5498516 |  | $26772387 |

---

&nbsp;&nbsp;&nbsp;&nbsp;

<sup>1</sup> Reflects the translation of the historical results of Alpha from GBP to USD using a period end spot rate of 1.3714 as of June 30, 2025.

------

**NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS**

**1. Pro Forma Basis of Presentation**

These unaudited pro forma condensed combined financial statements and notes thereto have been prepared in accordance with Article 11 Regulation S-X as promulgated by the SEC, as amended by the final rule Release No. 33-10786 "Amendments to Financial Disclosures about Acquired and Disclosed Businesses," in order to give effect to the Acquisition and the related transaction accounting adjustments (pro forma adjustments) described in these notes.

The unaudited pro forma condensed combined financial statements have been derived from the historical consolidated financial statements of Corpay and Alpha. The historical financial statements of Corpay were prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") and in its reporting currency of U.S. dollars ("USD"). The historical financial statements of Alpha were prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board and presented in pounds sterling ("GBP"). The unaudited pro forma condensed combined financial statements includes adjustments to translate the historical results of Alpha from GBP to USD using a period end spot rate of 1.3714 for the unaudited pro forma condensed combined balance sheet as of June 30, 2025 and average spot rates of 1.2973 and 1.2780 for the unaudited pro forma condensed combined statements of income for the six months ended June 30, 2025 and for the year ended December 31, 2024, respectively.

The Alpha financial statements presented in these unaudited pro forma condensed combined financial statements have been adjusted from IFRS to U.S. GAAP to conform with the Company's financial statements. The key difference between U.S. GAAP and IFRS relevant to the Alpha financial statements relates to lease accounting, discussed further below. Under IFRS, lessees account for all leases as finance leases, with the associated lease expenses recorded within interest expense and depreciation expense. Under U.S. GAAP, Alpha's leases, which were analyzed under Accounting Standards Codification Topic 842, "Leases", would be classified as operating leases with lease expense recognized on a straight-line basis as part of operating expenses.

The accounting policies of Alpha under IFRS, which are described in Note 2 to Alpha's historical consolidated financial statements included in this filing, are not expected to be materially different from U.S. GAAP, except for the adjustments related to the balance sheet classification of customer funds held for the benefit of others and the net balance sheet presentation of derivative asset and liability positions, discussed further below. Further review of Alpha's accounting policies and consolidated financial statements may result in additional revisions to Alpha's accounting policies and the presentation and disclosure of financial information to conform to those of Corpay.

Certain financial statement line items included in Alpha's historical presentation have been reclassified to conform to the corresponding financial statement line items included in Corpay's historical presentation. The classification of these items have no impact on the historical operating income, net income, total assets, total liabilities or stockholders' equity reported by Corpay or Alpha.

The unaudited pro forma condensed combined financial statements were prepared using the acquisition method of accounting with Corpay considered the acquirer of Alpha. The acquisition method of accounting is in accordance with Accounting Standards Codification Topic 805, *Business Combinations*. As the acquirer, Corpay has preliminarily estimated the fair value of the assets acquired and liabilities assumed from Alpha based on initial valuations performed by management and third-party specialists, which rely on management's estimates and assumptions, as well as other information compiled by management, including information from prior valuations of similar acquired entities and the books and records of Alpha. The fair value adjustments using the acquisition method of accounting reflected in the unaudited pro forma condensed combined balance sheet are preliminary and subject to adjustment based

------

on final determinations of fair value within the measurement period which is up to 12 months from the date of the Acquisition. Actual results may differ from the unaudited pro forma condensed combined financial information once the final acquisition accounting by the Company has been completed and the Company has determined the final purchase price for Alpha and has completed the valuation studies necessary to finalize the required purchase price allocations. There can be no assurance that such finalization will not result in material changes.

The unaudited pro forma condensed combined statements of income for the six months ended June 30, 2025 and for the year ended December 31, 2024 are presented as if the Acquisition had occurred on January 1, 2024. The unaudited pro forma condensed combined balance sheet as of June 30, 2025 is presented as if the Acquisition occurred on that date. The unaudited pro forma condensed combined statements of income of the Company for the six months ended June 30, 2025 and year ended December 31, 2024, have been prepared using the historical consolidated statements of operations of the Company and Alpha for the six months ended June 30, 2025 and year ended December 31, 2024, giving effect to the Company's acquisition of Alpha using the acquisition method of accounting and applying the assumptions and adjustments described herein. The unaudited pro forma condensed combined balance sheet of the Company as of June 30, 2025 has been prepared using the historical consolidated balance sheet data of the Company and Alpha as of June 30, 2025, giving effect to the Company's acquisition of Alpha using the acquisition method of accounting and applying the assumptions and adjustments described herein.

The unaudited pro forma condensed combined financial information has been prepared by management for illustrative purposes only and are not necessarily indicative of the consolidated financial position or results of operations in future periods or the results that actually would have been realized had the Company and Alpha been a combined company during the specified periods. The unaudited pro forma condensed combined financial statements do not reflect (i) the costs of any integration activities or benefits that may result from the realization of future revenue or cost synergies that are expected to result from the Acquisition or (ii) incremental costs associated with Alpha being a component of a publicly traded company.

**2. Pro Forma Adjustments**

The historical financial statements have been adjusted from IFRS to U.S. GAAP to conform with the Company's financial statements and to give effect to pro forma events that are (i) directly attributable to the Acquisition, (ii) factually supportable, and (iii) with respect to the statements of income, expected to have a continuing impact on the combined results of Corpay and Alpha. The following pro forma adjustments are included in the unaudited pro forma condensed combined financial statements.

**A.** Adjustments to reflect the reclassification of Alpha's historical results to conform to the Company's financial statement presentation for the year ended December 31, 2024 and for the six months ended June 30, 2025. The following table details these financial statement reclassification adjustments (in thousands, in USD):

------

---

| | | |
|:---|:---|:---|
| | **Year Ended December 31, 2024** | **Six Months Ended June 30, 2025** |
| Revenues, net | $109019 | $50789 |
| Net treasury income - client funds | (107349) | (50051) |
| Net treasury income - own funds | (1670) | (738) |
| Operating Expenses | (131136) | (101768) |
| Processing | 62343 | 38361 |
| Selling | 20789 | 15632 |
| General and administrative | 37405 | 42214 |
| Depreciation and amortization | 10599 | 5561 |
| Finance income | 7736 | 3877 |
| Finance expenses | (1577) | (1856) |
| Interest expense, net | (6159) | (2021) |
| Total | $— | $— |

---

The Company presents revenue in a single line item on the financial statements (Revenues, net) as opposed to separately presenting revenue by the funds used. The Company also separately presents categories of operating expenses as opposed to presenting operating expenses in a single line item. The Company also presents net interest income and expense as a single line item as opposed to presenting interest income and expense as separate line items.

**B.** Adjustment to record estimated incremental amortization expense of definite-lived intangibles acquired of $48.4 million and $95.3 million for the six months ended June 30, 2025 and the year ended December 31, 2024, respectively. The Company's estimated preliminary allocation of the purchase price to identified intangible assets is $1.0 billion, primarily comprised of customer relationships, trade names, and acquired technology. The amortization of definite-lived intangibles will be expensed over the relative estimated useful lives between 3 and 20 years. The definite-lived intangible assets are amortized over the period of time that the assets are expected to contribute directly or indirectly to future cash flows. The valuation and resulting amortization of the identifiable intangible assets acquired is preliminary and subject to change as the Company finalizes the review of key assumptions, inputs and estimates, and certain useful life assumptions.

Adjustment also reflects the removal of intangible amortization expense included in Alpha's historical statements of income of $4.6 million and $8.6 million for the six months ended June 30, 2025 and the year ended December 31, 2024, respectively.

**C.** Adjustments of $2.7 million and $4.6 million for the six months ended June 30, 2025 and the year ended December 31, 2024, respectively, to convert leases accounted for and recorded under IFRS 16 to ASC 842 which includes recording the estimated lease expense for Alpha's operating leases within general and administrative expense and to reflect the required re-measurement of Alpha's lease portfolio as of October 31, 2025 upon acquisition, updated for the Company's estimated incremental borrowing rates as of that date.

Adjustment also reflects the removal of Alpha's historical lease expense of $2.5 million and $4.9 million for the six months ended June 30, 2025 and the year ended December 31, 2024, respectively, which was reflected as depreciation expense and $0.8 million and $1.6 million for the six months ended June 30, 2025 and the year ended December 31, 2024, respectively, within interest expense.

------

**D.** Adjustment to record the Company's best estimate of additional incremental expenses incurred by the Company had Corpay acquired Alpha on January 1, 2024. Adjustment is primarily related to incremental transaction-related professional service fees including consulting, accounting, legal and tax fees as well as employee compensation related to retention arrangements. Adjustment results in incremental expense of approximately $1.1 million for the six months ended June 30, 2025 and $95.2 million for year ended December 31, 2024, respectively. Adjustments are forward-looking in nature.

**E.** Adjustment reflects the impact of incremental interest expense related to the Company's financing-related actions in connection with the Acquisition. The Company financed the Acquisition primarily through borrowings under its Credit Agreement, namely a new seven-year, $900 million Term Loan B and incremental Revolver B borrowings of $1 billion under its existing revolving line of credit facility. The new Term B and revolver debt has been assumed to bear interest based on the Secured Overnight Financing Rate plus a margin adjustment, or 5.7% for the Term B borrowings and 5.5% for the Revolver B borrowings, resulting in estimated interest expense within the pro forma results of approximately $50.0 million for the six months ended June 30, 2025 and $98.6 million for the year ended December 31, 2024.

A one-eighth of a percentage change in interest rates would result in a change in interest expense of $1.1. million for the six months ended June 30, 2025 and $2.2 million for the year ended December 31, 2024.

Adjustment for the year ended December 31, 2024, also reflects the amortization of approximately $9.8 million in debt issuance costs related to a £1.875 billion bridge facility that the Company entered into in connection with the announced acquisition of Alpha. The Company did not utilize the bridge term loan for the financing of the acquisition. The bridge term loan facility expired on November 7, 2025.

Adjustment also reflects the amortization of debt issuance costs and debt discounts related to the Company's incremental borrowings, as if such borrowings had been entered into on January 1, 2024, of approximately $1.9 million for the six months ended June 30, 2025 and $3.7 million for the year ended December 31, 2024.

**F.** Adjustment to remove the noncontrolling interest activity within Alpha's historical financial statements. In connection with the Acquisition, the Company also acquired the remaining interest of Cobase, of which Alpha had previously owned 86%. The unaudited condensed combined pro forma financial statements reflect the full ownership of Cobase and inclusion of the full income statement results for Cobase, as if such transaction had been entered into on January 1, 2024.

**G.** Adjustments to record the income tax effect of all pro forma adjustments recorded using the blended statutory rate in effect for the Company of 25.7% for the year ended December 31, 2024 and for the six months ended June 30, 2025.

------

**H.** Adjustments to reflect the reclassification of Alpha's accounts to conform to the presentation of the Company's balance sheet at June 30, 2025. The following table details these financial statement reclassification adjustments (in thousands, in USD):

---

| | |
|:---|:---|
| | **6/30/2025** |
| Restricted cash | $14128 |
| Fixed collateral | (14128) |
| Derivative financial assets | (329781) |
| Prepaid expenses and other current assets | 329781 |
| Total current assets |  |
| Right-of-use assets | (24253) |
| Derivative financial assets | (126480) |
| Other assets | 150733 |
| Total noncurrent assets |  |
| **Total assets** | **—** |
| Derivative financial liabilities | (131112) |
| Other payables | (150666) |
| Redemption liability | (949) |
| Deferred income | (12119) |
| Lease Liability | (3652) |
| Current tax liability | (16387) |
| Other current liabilities | 314885 |
| Total current liabilities |  |
| Derivative financial liabilities | (54939) |
| Other payables | (1249) |
| Redemption liability | (2625) |
| Deferred tax liability | (3935) |
| Lease liability | (26460) |
| Deferred income taxes | 3935 |
| Other noncurrent liabilities | 85273 |
| Total noncurrent liabilities |  |
| **Total liabilities** | **—** |

---

**I.** When the Company determines it has control over customer funds held for the benefit of others in accordance with U.S. GAAP and the Company's accounting policies, as well as its capital allocation and working capital strategy, the Company recognizes the related asset and liability on its balance sheet. Such amounts were excluded from Alpha's historical balance sheet as Alpha had concluded that it did not exercise sufficient control over such funds. Corpay concluded that it has control over these funds and therefore has recognized and presented it as a pro forma adjustment. The balance of client funds representing a pro forma adjustment to restricted cash and customer deposits is $3.7 billion.

Adjustment also reflects accounting policy conformity related to the Company's application of U.S. GAAP in determining the net balance sheet presentation of Alpha's derivative asset and liability positions. The fair values of derivative assets and liabilities associated with contracts, which include netting terms that the Company believes to be enforceable, have been recorded on a net basis within prepaid expenses and other current assets, other assets, other current liabilities and other noncurrent liabilities. Cash collateral amounts are recorded within restricted cash and customer deposits.

------

The Company continues to perform a detailed review of Alpha's historical financial statements. As a result of that review, the Company may identify additional differences between the accounting policies of the two companies that, when conformed, could have a material impact on the combined financial statements.

**J.** Adjustment to reflect the required remeasurement of Alpha's lease portfolio as of October 31, 2025 upon acquisition, utilizing the Company's estimated incremental borrowing rates as of that date, resulting in (i) an increase to other assets of $6.0 million; (ii) an increase to other current liabilities of $2.4 million and (iii) an increase to other noncurrent liabilities of $3.1 million.

**K.** Adjustment to eliminate the historical retained earnings and equity balances of Alpha and acquisition of remaining Cobase noncontrolling interest along with the Alpha transaction.

**L.** Adjustment to eliminate the historical goodwill and other intangibles balances of Alpha of $6.4 million and $20.7 million, respectively.

**M.** Adjustment to record the preliminary valuation of the fair value of identifiable intangible assets and goodwill acquired. The Company's estimated preliminary allocation of the purchase price to identified intangible assets is $1.0 billion, primarily comprised of customer relationships, trade names, and acquired technology. The amortization of definite-lived intangibles will be expensed over the relative estimated useful lives between 3 and 20 years. The valuation and resulting amortization of the identifiable intangible assets acquired is preliminary and subject to change as the Company finalizes the review of key assumptions, inputs and estimates, and certain useful life assumptions.

Adjustment also reflects the recognition of estimated deferred tax liabilities of $267 million associated with the acquisition of intangible assets using a blended statutory rate of 25.7%. All of the goodwill attributable to the acquisition of Alpha is expected to be deductible for tax purposes.

**N.** Adjustment reflects acquisition related expenses incurred by the Company and Alpha for the Acquisition.

**O.** Adjustment reflects the preliminary determination of consideration transferred of $2.5 billion, net of $49.2 million cash payment ineligible for inclusion in purchase price. Specifically, (i) $25.8 million recorded to retained earnings to reflect buyer-side acquisition costs expensed immediately by Corpay at the acquisition date and (ii) $23.5 million recorded to other assets representing prepaid compensation earned by Alpha employees as future service is rendered. None of the consideration transferred is contingent.

**P.** Adjustment reflects the impact of the Company's borrowings to finance the Acquisition. The Company financed the Acquisition primarily through borrowings under its Credit Agreement, namely its new seven-year, $900 million Term Loan B and incremental Revolver B borrowings of $1 billion under its existing revolving line of credit facility.

As a result of the Term Loan B and Revolver B borrowings, the Company capitalized debt issuance costs of approximately $14.8 million. Adjustments on the pro forma balance sheet reflect the incremental impact of debt issuance costs incurred, resulting in (i) a decrease to cash and cash equivalents of $14.8 million; (ii) an increase to other assets of $3.8 million for amounts allocated to the Revolver B and (iii) a decrease to notes payable and other obligations, less current portion of $11.0 million for amounts allocated to the new Term Loan B at June 30, 2025.

**Q.** Adjustment also reflects the amortization of approximately $10.5 million in debt issuance costs related to obtaining a £1.875 billion bridge facility that the Company entered into in connection with the announced Acquisition. The Company did not utilize the bridge term loan for the financing of the Acquisition. The bridge term loan facility expired on November 7, 2025.

<br>